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Abstract 
An appropriate genetic counselling is essential when a genetic test is offered. However, to 
assess genetic counselling quality is a challenge for clinical genetics services worldwide 
due to the scarcity of effective tools to this effect. In Portugal, professionals and services 
have been demanding effective tools which allow evaluation of the quality of their services 
and consequently improving their practice and counselees care. This thesis describes the 
development and psychometric validation of a multidimensional scale for quality 
assessment of genetic counselling by the counselees. The formulation of the items and their 
organization were based on a Portuguese scale designed for quality assessment of genetic 
counselling by the healthcare professionals. After a pre-test validation, the scale was 
submitted to a psychometric validation using a sample of 107 counselees, 73 women and 
32 men, aged 18 to 75 years old (M = 40.5; SD = 16.28), who had a genetic counselling 
consultation in a Portuguese clinical genetics service, between September of 2018 and May 
of 2019. A principal component analysis was performed to examine the scale structure. 
The construct validity and internal consistency were also evaluated. The results from the 
principal component analysis indicated good psychometric proprieties for the ‘counselee’s 
education’, ‘counselee’s knowledge and understanding’, ‘counselee’s individual 
attributes’, ‘relationship and communication issues’, ‘potential effects’ and ‘services 
provision’ dimensions. Internal consistency of each dimension ranged between .70 and .90 
(Cronbach’s ɑ), excepted for the dimension ‘counselee’s knowledge and understanding’ 
that presented a Cronbach’s alpha of. 60. As expected, all dimensions were positively and 
significantly correlated with each other. The results show that the scale may be a useful 
instrument for clinicians, services and researchers interested in monitoring the quality of 
genetic counselling.  
 
Keywords: genetic counselling; quality assessment tool; clinical genetics services; 
psychometric validation 
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Resumo 
É essencial assegurar a oferta de um aconselhamento genético apropriado aquando da 
realização de um teste genético. No entanto, avaliar a qualidade do aconselhamento 
genético ainda é um desafio para os serviços de genética devido à escassez de ferramentas 
disponíveis para esse efeito. Em Portugal, profissionais e serviços têm vindo a reivindicar 
ferramentas efetivas que lhes permitam avaliar a qualidade dos seus serviços e, 
consequentemente, melhorar a sua prática, e os cuidados prestados aos consultandos. Esta 
dissertação descreve o processo de desenvolvimento e validação de uma escala 
multidimensional para a avaliação da qualidade do aconselhamento genético pelos 
consultandos. A formulação dos itens e a sua organização foram baseadas na escala 
portuguesa para avaliação da qualidade do aconselhamento genético pelos profissionais de 
saúde. Depois de um pré-teste, a escala foi submetida a validação psicométrica utilizando 
uma amostra de 107 consultandos, 73 mulheres e 32 homens, com idades compreendidas 
entre os 18 e os 75 anos (M = 40.5; DP = 16.28), que tiveram uma consulta de 
aconselhamento genético num serviço de genética nacional, entre os meses de setembro de 
2018 e maio de 2019. Foi realizada uma análise de componentes principais para examinar 
a estrutura da escala. A validade de construto e a consistência interna foram também 
avaliadas. Os resultados da análise de componentes principais indicam que as dimensões 
‘educação’, ‘compreensão’, ‘características do consultando’, ‘relação profissional-
consultando’, ‘efeitos do processo’ e ‘prestação de serviços’ apresentam uma estrutura 
consistente. A consistência interna de cada dimensão variou entre .70 e .90 (ɑ de 
Cronbach), com exceção da dimensão ‘compreensão’ que apresentou um alfa de Cronbach 
de .60. Como esperado, todas as dimensões apresentaram correlações positivas e 
significativas entre si. Os resultados indicam que a escala pode ser um instrumento útil 
para profissionais de saúde, serviços e investigadores interessados em monitorizar a 
qualidade do aconselhamento genético. 
 
Palavras-chave: aconselhamento genético; instrumento de avaliação da qualidade; 
serviços de genética; validação psicométrica 
 
vii 
 
Résumé  
Assurer l’offre d’un conseil génétique approprié est essentiel lors de la validation d’un test 
génétique. Toutefois, évaluer la qualité d’un conseil génétique est encore un défi pour les 
services de génétique car il y a peu d’outils disponibles pour l’effectuer. Au Portugal, les 
professionnels et les services continuent à réclamer des outils capables d’évaluer la qualité 
de leur service, donc d’améliorer leur pratique ainsi que les soins fournis à ceux qui sont 
consultés. Cette dissertation décrit le processus du développement et la validation 
psychométrique d’une échelle multidimensionnelle pour permettre l’évaluation de la 
qualité du conseil génétique, par ceux qui sont consultés. L´élaboration des questions et 
leur organisation ont été conçues à partir d’une échelle portugaise pour évaluer la qualité 
du conseil génétique des professionnels de santé. Après un pré–test, l’échelle a été soumise 
à la validation psychométrique pour un échantillon de 107 personnes qui ont été 
consultées, 73 femmes et 32 hommes, âgées entre 18 et 75 ans (M = 40.5; S =16.28), qui 
ont eu un rendez-vous d’avis génétique dans un service de génétique national, entre les 
mois de septembre 2018 et mai 2019. On a fait une analyse des composants principaux  
pour observer la structure de l’échelle. La validité de la construction et la consistance 
interne ont été aussi évaluées. Les résultats de l’analyse des composants principaux 
indiquent  que les dimensions ‘éducation’, ‘compréhension’, ‘caractéristiques de ceux qui 
sont consultés’, ‘relation professionnel-consulté’, ‘effets du processus’ et ‘prestation de 
services’ présentent une structure consistante. La consistance interne de chaque dimension 
a varié entre .70 e .90 (ɑ de Cronbach), à l’exception de la dimension ‘compréhension’ qui 
a présenté un alpha de .60. Comme prévu, toutes les dimensions présentent des corrélations 
positives et significatives entre elles. Les résultats indiquent que l’échelle peut être un 
instrument utile pour les professionnels de santé, services et rechercheurs qui s’intéressent 
à l’évaluation du conseil génétique. 
 
 
Mots-clés: conseil génétique; instrument d’évaluation de la qualité; services de génétique; 
validation psychométrique 
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Introduction 
Due to the completion of the sequencing of the Human Genome and the huge 
development in genetic testing technologies, the field of genetics has grown rapidly 
(Ormond et al., 2018). The greater application of genetics knowledge and technologies in 
medicine has increased both interest in and concern about the impact of genetics 
information on the life of individuals and families at-risk or affected by a genetic condition 
(Rantanen et al., 2008) because many of these diseases have no treatment or cure (Wang, 
Gonzalez, & Merajver, 2004). For this reason, genetic counselling (GC) has been evolving 
and acquiring greater importance in genetics healthcare over the last decades (Ormond et 
al., 2018). In spite of its evolution and increasing importance, the evaluation of its quality 
remains a challenge for clinical genetics services (CGS) worldwide given the absence of 
effective tools available to this effect (Payne et al., 2008). In the national literature, this 
lack of tools is pointed out as a constraint to the affirmation of GC in Portugal (Paneque, 
Mendes, Saraiva, & Sequeiros, 2015b). Due to this demand, a Portuguese tool for quality 
assessment of GC by healthcare professionals was recently developed (Costa, 2017; 
Paneque et al., 2018). However, when evaluating the quality of GC, it is also important to 
include the perspective of the counselees because they are the real beneficiaries of the GC. 
Additionally, only the evaluation of both professionals’ and counselees’ perspectives will 
allow a comprehensive evaluation of GC quality. Therefore the main purposes of the 
present thesis are to develop and validate a scale for counselees’ evaluation of GC quality.  
This thesis is organized in five chapters. In the first chapter, a review of the literature 
about the quality evaluation of GC and in particular the counselees’ perspective of GC will 
be presented. In the second chapter, the empirical study will be explained in detail. In the 
third chapter, the results will be described. In the fourth chapter, the results will be 
discussed and the study’s theoretical and practical implications and recommendations for 
future studies will be addressed. Finally, in the last chapter, a summary of the main 
conclusions and implications of the study will be presented. 
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I. Theoretical Framework 
1.1.  Genetic Counselling  
GC is a relatively recent (≈45 years) interdisciplinary field that aims to address the 
needs of both people and families affected by or at risk for a genetic condition (Ormond et 
al., 2018; Paneque, Sequeiros, & Skirton, 2012; Redlinger-Grosse et al., 2016). 
The term GC was coined in 1947 by Dr. Sheldon C. Reed (McCarthy Veach, Bartels, 
& LeRoy, 2003). Over the years, the definition of GC has been changed as a consequence 
of the evolution of the field and changes in its goals (Resta, 2006). One of the most often 
cited definitions of GC is Fraser’s (1974), in which GC is conceptualized as: 
 
A communication process which deals with the human problems associated with the occurrence, or 
risk of occurrence, of a genetic disorder in a family. This process involves an attempt by one or 
more appropriately trained person to help the individual or the family to comprehend the medical 
facts, including the diagnosis, the probable course of the disorder and available management, to 
appreciate the way heredity contributes to the disorder and the risk of recurrence in specified 
relatives, to understand the options for dealing with the risk of recurrence, to choose the course of 
action which seems appropriate to them in view of their risk and their family goals and act in 
accordance with that decision, and to make the best possible adjustment to the disorder in an 
affected family member and to the risk of recurrence of that disorder. (p. 637) 
 
As this definition underlines, in a GC process, the counsellor presents medical and 
genetics information about the condition to the counselees, explaining its possible 
consequences, the probability of developing the disease or transmitting it to their offspring, 
and what can be done to prevent or ameliorate the condition (Pilnick & Dingwall, 2001). In 
Baty’s words “genetic counsellors help families learn from the past, adjust to the present, 
and predict the future” (2018, p. 59). The counsellor also attempts to aid counselees to give 
meaning to the information received and to decide the course of action that seems more 
appropriate to them in relation to the genetics disease that affects the family (Pilnick & 
Dingwall, 2001). This psychosocial component of GC is greatly emphasized by some 
authors, such as Austin, Semaka and Hadjipavlou (2014) and McCarthy Veach, Bartels and 
LeRoy (2003) who define GC as an interdisciplinary area of clinical healthcare in which 
knowledge of genetics and counselling skills are combined to support people to cope better 
with medical information and psychosocial aspects of genetics diseases or the at-risk status 
(Baty, 2018).  
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Since its early years, GC has expanded and evolved steadily due to the advancement 
in genetic testing technology (e.g., whole genomic sequencing or the development of new 
genetic tests), the increasing genetics knowledge about disease etiology, the progressive 
integration of genetics into primary care settings, and the incremental population demand 
for genetics disease prevention, treatment and monitoring  (Chou et al., 2018; Payne et al., 
2008; Redlinger-Grosse et al., 2016; Ormond et al., 2018). With the proliferation of genetic 
tests for more medical conditions, GC has become an important component of healthcare 
across diverse sub-specialties of medicine, such as obstetrics, paediatrics, neurology, 
endocrinology, haematology, cardiology and oncology. This growth has led to a greater 
professionalization of the field, an increase of genetic counsellors around the world, as 
well as to greater recognition of GC by the general population (Baty, 2018; Ormond et al., 
2018). However, this development is not occurring at the same pace in all countries, due to 
the constraints related to the functioning of healthcare systems, legal restrictions, and 
social or cultural norms (Ormond et al., 2018).  
 
1.1.1. The Development of Genetic Counselling in Portugal. 
In Portugal, GC arose in the nineties with the implementation of the first national 
programme for pre-symptomatic testing (PST) (Paneque et al., 2015b). Since then, GC has 
been regulated by the Portuguese law 12/2005 which establishes that a genetic test (e.g., 
prenatal, pre-symptomatic, predictive, susceptibility) can only be carried out after a GC 
consultation and written informed consent. The same law also determines that all citizens 
have the right to receive GC before and after a genetic test. Later, in 2009 the first 
Portuguese professional master’s program in GC was set up at the Institute of Biomedical 
Sciences Abel Salazar (University of Porto). Despite these historical achievements, GC 
and the profession of genetic counsellor remain without full professional recognition in 
Portugal
1
. The number of professionals working in the field is still insufficient, and there 
are gaps in the professionals’ training (Paneque et al., 2015b; Paneque, Mendes, 
Guimarães, Sequeiros, & Skirton, 2015a). According to Paneque and colleagues (2015b) 
factors such as the heterogeneity of standards of practice, the poor coordination between 
                                                             
1
Given that the profession of genetic counsellor is not still recognized in Portugal. The term professional will 
be used to refer who is providing the genetic counselling consultation.  
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national teams, the scarcity of human resources, the educational and training needs and the 
absence of effective tools for professionals to assess the quality of their services are 
constraining the development and the full implementation of the GC in Portugal (Paneque 
et al., 2015b).   
 
1.2.  The Evaluation of Genetic Counselling Quality 
With the increasing importance of genetics in healthcare, it has become essential to 
ensure that the GC professionals and services are meeting the counselee’s needs and that 
they are providing appropriate care (DeMarco, Peshkin, Mars, & Tercyak, 2004; Wang et 
al., 2004; Rantanen et al., 2008). The constant monitoring and improvement of GC quality 
are therefore priorities for professionals and clinical genetics services (CGS)
2
 because both 
are critical for the advancement of GC as an independent and recognized profession 
(DeMarco et al., 2004; Paneque et al., 2015b).  
The quality assessment of GC practice is not a new theme or a new concern in the 
field. In the nineties, Lea (1996) defined the quality of GC as “a range of desirable 
outcomes of patient encounters and encompasses effectiveness, efficiency, adequacy, and 
acceptability” (p. 125). Since Lea’s work, an effort has been made by clinical genetics 
professionals and CGS to develop routines and tools to assess the quality of their services 
(McAllister, Wood, Dunn, Shiloh, & Todd, 2011b). However, the rigorous assessment of 
the quality of GC remains a challenge for professionals and services worldwide 
(Guimarães, Sequeiros, Skirton, & Paneque, 2013; McAllister et al., 2011b; Paneque et al., 
2012; Paneque et al., 2015b). As a consequence, globally, the quality evaluation in the 
field of GC is behind other areas of healthcare (Chou et al., 2018). This context, together 
with the absence of effective tools reported in Portugal and the studies' limitations 
discussed below, were the main reasons for aiming to develop and validate a scale for GC 
quality assessment by counselees in the present research. 
Quality evaluation is still a neglected topic in the field, although some authors 
support its key role in the GC development and affirmation (Paneque et al., 2015b). 
                                                             
2
Defined here as health services that offer genetic consultations, genetic counselling and genetic 
testing/screening (Wang et al., 2004).   
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Among the scarce studies focusing on these constructs, those centered on oncogenetic 
context are probably the most prevalent. In addition to the paucity of research on quality 
evaluation, the existing studies seem to have some methodological limitations (Guimarães, 
et al., 2013; Paneque et al., 2012; Rantanen et al., 2008). First, there is a lack of 
consistency regarding the conception of GC nature, goals and foci (process vs effects) 
adopted across studies. Some studies advance inclusively with effect criteria without 
previously specifying the definition and the goals of GC, and/or without a proper 
theoretical framework (Paneque et al., 2012). Secondly, almost all studies use cross-
sectional designs, self-report instruments and small and not representative samples (i.e., 
participants are from self-selected populations, usually caucasian and from higher 
socioeconomic levels) (McCarthy Veach, Bartels, & LeRoy, 2007).  
 
1.2.1.  How to Evaluate Genetic Counselling Quality?. 
Few studies examined how to evaluate the quality of GC (Guimarães et al., 2013; 
Paneque et al. 2012; Rantanen et al. 2008). However, it is possible to distinguish two major 
approaches: (a) to assess the GC as a process, and (b) to evaluate solely its potential effects 
or outcomes (Guimarães et al., 2013; McCarthy Veach et al., 2007).  
The first approach is focused on aspects, such as how information is provided, time 
given to counselee to talk about their concerns and needs, and quality of the professional-
counselee relationship (Bernhardt, Biesecker, & Mastromarino, 2000; Guimarães et al., 
2013; McAllister et al., 2008b). The importance of the process aspects have been claimed 
by some authors, such as Paneque and colleagues (2015b), Pilnick (2002) and Rantanen 
and colleagues (2008), but few studies examined their contribution to the effects or 
outcomes (Chou et al., 2018; Rantanen et al., 2008; Pithara, 2014).  
The second approach, in contrast, is more concerned with aspects, such as changes in 
reproductive behaviour, counselee’s knowledge about the disease, satisfaction, perceived 
risk, and perceived control (Madlensky et al., 2017; McAllister et al., 2008b; McAllister, 
Dunn, & Todd, 2011a; Redlinger-Grosse et al., 2016; Payne et al., 2007). Despite the 
widespread adoption of this approach, there is still no consensual set of desirable effects or 
outcomes that should be applied to the evaluation of the GC quality (Chou et al., 2018; 
McAllister et al., 2011a). 
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1.2.2. Genetic Counselling Quality Indicators. 
Although there is still no consensual and standard set of indicators for the quality 
assessment of GC (Payne et al., 2008), some proposals have already been advanced.  
The EuroGentest (as cited in Guimarães et al., 2013) have produced a web-based 
checklist to assess logistics of genetics services consisting of eleven quality indicators of 
the GC practice: (a) size of and collaboration in the unit, (b) staff education, (c) physical 
environment and access, (d) waiting times, (e) prerequisite of counselling, (f) language, 
culture and communication, (g) decision-making process and consent, (h) counselee 
experience, (i) extended support, (j) post-consultation measures, and guidelines.  
More recently, Chou and colleagues (2018) have developed a set of comprehensive 
quality metrics to inform quality improvement efforts in state genetics service delivery 
formed by the following sixteen quality indicators: (a) availability of and support for 
preconception services (e.g., folic acid education); (b) information referral and 
coordination (e.g., referral of families to support groups); (c) quality improvement (e.g., 
adherence to licensing requirements, published guidelines, standards, and regulations); (d) 
early screening and diagnosis (e.g., offer prenatal tests such as maternal serum α-
fetoprotein and associate marker screening); (e) family or individual feedback (e.g., 
collects feedback from individuals and families concerning genetics services); (f) state 
provision of access to genetics services (e.g., provides access or has mechanisms in place 
to facilitate access to genetics services such as estate funds); (g) access to genetics 
professionals (e.g., the state employs or give access to specialized professionals); (h) 
accessibility/availability to genetics services (e.g., to establish a maximum time to a 
medical appointment); (i) genetics medical records (e.g., informed consent for visit is 
maintained as a part of the permanent medical record); (j) patient ratings of physician–
patient interaction (e.g., the professional listened carefully); (l) security of electronic 
information (e.g., the service has a plan about security and computer access); (m) 
documentation of data sources (e.g., the state uses certain data sources as population-based 
cancer/tumor registry); (n) data linkages (e.g., the state has or has access to information 
systems or databases as the birth defect registry); (o) components of newborn screening 
program (e.g., the state has a standardized newborn’s screening program formed by 
different components); (p) state staffing (e.g., the state has a designated genetics 
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coordinator); and (q) workforce training adequacy (e.g., the state implements strategies to 
meet the staff needs).  
Overall, given that both sets of quality indicators are mainly focused on logistical 
and/or services provision factors, there is a clear need for a comprehensive set of quality 
indicators that includes other core components of GC, such as consultation contents, 
professional-counselee relationship and potential effects of the GC process for the 
counselee (Paneque et al., 2012).  
 
1.2.3. Measures of Genetic Counselling Quality. 
The tools used for quality assessment seem to be insufficient, and/or poorly 
disseminated amongst the professional community (Payne et al., 2008). The majority of the 
available tools are mainly focused on specific effects or outcomes, such as satisfaction with 
GC (e..g., DeMarco et al., 2004), knowledge (e.g., Erblich et al., 2005), decision-making 
(e.g., Michie, Dormandy, & Marteau, 2002), perceived control (e.g., Berkenstadt, Shiloh, 
Barkay, Katznelson, & Goldman, 1999), familial communication (e.g., Mesters et al., 
1997). Or they are intended to audit the CGS focusing only in factors related to the 
services provision (e.g., Skirton, Parsons, & Ewings, 2005) (see Appendix A for a 
complete description of the main tools). Of interest to the present study, none of the 
existent measures seem able to evaluate all the specific aspects which may contribute to the 
quality of GC (Chou et al., 2018; Paneque et al., 2018; Payne et al., 2008; Redlinger-
Grosse et al., 2016).  
 
1.2.4.   The Evaluation of Genetic Counselling Quality in Portugal. 
The difficulties in defining indicators and the best way for measurement of GC 
quality are also felt in Portugal. According to Paneque and colleagues (2015a), there is a 
general lack of knowledge and reflection about quality indicators, as well as a scarcity of 
tools to assess the quality of the GC, and a lack of quality assessment routines in the 
national genetics services. In turn, this absence of theoretical-driven and appropriate 
methodological tools to evaluate the quality of GC hinders an adequate audit of CGS and 
the continuous improvement of genetics practice and services.  
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In order to overcome this absence of tools to evaluate the GC quality, Paneque and 
colleagues (2018) recently developed a tool for professionals working in the GC field to 
assess the quality of their practice. However, the need for an instrument for counselee’s 
evaluation of the quality of GC remains. 
 
1.3.  A Portuguese Tool for Genetic Counselling Quality Assessment by Professionals 
The Portuguese tool for quality assessment of GC is a multidimensional scale 
designed for GC professionals’ evaluation of the quality of their practice.  
This scale has fifty items organized in five GC quality dimensions: (1) ‘education’; 
(2) ‘counselee’s characteristics’; (3) ‘professional-counselee relationship’; (4) ‘effects of 
the process in the counselee’; and (5) ‘services provision’. 
The scale was submitted to psychometric validation with a sample of thirty health 
professionals working in the field who evaluated eighty-one consultations carried out at 
main national genetics services (Paneque et al., 2018). The results of the validation process 
showed that the tool has good psychometric properties (see Table 1 for a detailed 
description of the scale dimensions, number of items, components and percentages of total 
variance explained). According to the cumulative percentage of the variance of the 
components of each dimension, the scale has a good construct validity (Paneque et al., 
2018). Moreover, the dimensions presented a good internal consistency (.83 ≤ α of each 
dimension ≤ .92).  
Despite being a new tool, this pioneer scale stands out from the remaining tools 
because it seeks to enable a comprehensive understanding of GC quality, considering both 
process-effects relationship and services provision dimensions. Furthermore, it is based on 
Reciprocal-Engagement Model (REM), the first proper model of GC practice (Paneque et 
al., 2018; McCarthy Veach et al., 2007). Given its clinical usefulness, the scale was 
received with great interest by Portuguese professionals, and professionals from Norway, 
Spain, France and Australia have already manifested interest in its cross-cultural adaptation 
and validation (Paneque et al., 2018).  
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Table 1 
Structure of the Portuguese tool for genetic counselling quality assessment 
Dimension Number of Items Components Total Variance 
Explained 
 
 
Education 
 
 
12 
To ensure the 
comprehension 
42.54% 
To provide genetics 
information 
16.47% 
To establish a mutual 
agenda 
10.15% 
 
Counselee’s 
characteristics 
 
11 
Emotional experience 
and motivations 
59.24% 
Decision-making 
support 
14.20% 
 
 
Professional-Counselee 
relationship 
 
 
 
11 
Therapeutic relationship 44.46% 
Counselee’s acceptance 12.60% 
Reflexive Practice 10.35% 
Professionalism 9.36% 
Effects of the process in 
the counselee 
9 Empowerment 59.50% 
 
 
Services provision 
 
 
8 
Services organization 54.32% 
Preparation of the 
counselee to the 
consultation 
16.74% 
Note. Adapted from “Proposta de uma escala portuguesa para a avaliação da qualidade do aconselhamento genético: Uma 
nova ferramenta para os profissionais da saúde by M. Paneque, C. Costa, C. Lemos, M. Alves Ferreira, J. Sequeiros and 
M.S. Lemos, 2018, Acta Médica Portuguesa, p. 325.   
  
1.4.  The Counselee’s Perspectives of Genetic Counselling 
To develop a tool for counselee evaluation of the quality of GC it is essential to 
understand how counselees perceive the GC and CGS, namely what are the aspects that 
they consider most important and beneficial because these aspects may constitute potential 
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quality indicators of GC (Payne et al., 2008). A brief literature review
3
 of the main 
counselee’s perceptions and views about GC and CGS was then performed. The major 
aspects identified were organized in clusters (see Table 2).  
Table 2 
Counselee’s views and perceptions of genetic counselling and clinical genetics services 
Genetic Counselling Clinical Genetics Services 
Quality of the professional-counselee relationship Practical and logistical aspects 
Process factors Tailored family care 
Professional’s characteristics and skills Openness to establishing long-term 
relationships 
Perceived effects or outcomes  
 
Within the field of counselee’s perspectives of GC, the quality of the professional-
counselee relationship is perhaps the most cited aspect (Bernhardt et al., 2000; Guimarães 
et al., 2013; Macleod, Craufurd, & Booth, 2002; McAllister et al., 2008a, 2008b; Skirton, 
2001). The counselees seem to value the establishment of a positive and empathic 
interpersonal relationship with the professional (McAllister et al., 2008a, 2008b). 
Counselees’ perceptions about the quality of the relationship appears to be related to some 
professionals’ skills, such as compassion, empathy, responsiveness, attentiveness, 
flexibility, engagement, confidence, sensitivity and supportiveness (McCarthy Veach, 
Truesdell, LeRoy & Bartels, 1999).  
Some factors related to the GC process are also mentioned by counselees (Bernhardt 
et al., 2000; MacLeod et al., 2002; McAllister et al., 2008a, 2008b). Among them, two 
deserve special mention given their frequency: the time spent with the professional and 
how information is provided (McAllister et al., 2008a). Feeling they have time to talk 
about their doubts and concerns without hurries or pressures is important for the 
counselees. Being offered information in an accessible and lay language, without medical 
jargons, and adjusted to their previous knowledge is also relevant for counselees. 
Regarding the practice model adopted by the professional, the counselees seem to 
                                                             
3
Studies developed on oncogenetic context were not included given the proper specificities of this context 
and the unique needs of this group of counselees.   
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appreciate a non-directive and patient-centred stance (Bernhardt et al., 2000; Costal Tirado 
et al., 2017; Paneque et al., 2015a; Skirton, 2001).       
The professional’s characteristics and skills are equally considered relevant by 
counselees (Bernhardt et al., 2000; Davey, Rostant, Harrop, Goldblatt, & O’Leary, 2005; 
MacLeod et al., 2002; McAllister et al., 2008a, 2008b; Paneque et al., 2015b). Some 
professional’s skills valued by counselees include the ability to listen, the capacity to 
empathize, social competence, ability to explore and address doubts and emotions, 
communication skills, open attitude, and the ability to answer the counselee’s questions 
(McCarthy Veach et al., 1999). Another aspect very frequently mentioned by counselees is 
the perception of the professional as an expert or as a reliable source of knowledge. This 
seems to be a very important aspect to counselees because it contributes to the feeling of 
being understood and to the feeling that their problem has been validated by an expert, 
which is reassuring for counselees (MacLeod et al., 2002; McAllister et al., 2008a).  
The aspects related to the perceived benefits of GC are also mentioned by 
counselees. Among the perceived benefits it is possible to highlight a better family 
communication of genetics information, the enhancement of understanding about the 
genetic condition, the greater facility in decision-making about the genetic condition, the 
relief of uncertainty and feelings of vulnerability, the decrease of anxiety about the genetic 
family condition, and the recovery of some confidence and control over their lives 
(Bernhardt et al., 2000; Guimarães et al., 2013; McAllister et al., 2008a, 2008b; McAllister 
et al., 2011b; McCarthy Veach et al., 1999; Pithara, 2014). 
In relation to counselee’s perceptions and views about CGS, three aspects are usually 
mentioned in the literature: (a) practical and logistical issues, (b) tailored family care and 
(c) openness to establish long-term relationships. Regarding the practical and logistical 
issues, it is important to counselees that the services are local, accessible and have open 
access. The duration of consultations is also relevant, as well as the proximity and privacy 
of the service, the kindness and availability of the administrative staff, the physical 
environment, the reduced waiting time for the consultation, the multidisciplinary approach, 
and the number of the available consultations (Bernhardt et al., 2000; Guimarães et al., 
2013; McAllister et al., 2008b; Paneque et al., 2012). 
Tailored family care is another aspect perceived as relevant by counselees. This 
aspect is related to the fact that in some services the GC is offered not only to the 
counselees but also to other members of their families (MacLeod et al., 2002). This 
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availability gives to the family the opportunity to make informed decisions about their 
family life, to clarify the risk to the wider family, and to improve their communication 
about the genetic disease (McAllister et al., 2008a), therefore contributing to improve 
counselees hope for their own future and for their offspring future (McAllister et al., 
2008a). 
The openness to establishing long-term relationships across the follow-up 
consultations is another aspect valued by counselees. This issue is important to counselees 
because diverse doubts and questions can emerge at different life stages and for different 
family members so it is useful to have access to the service over time (McAllister et al., 
2008a; Pithara, 2014). Besides that, this openness allows the establishment of an ongoing 
supportive relationship with the professional (Bernhardt et al., 2000), which is also 
appreciated by the counselees. 
In general, these aspects seem to be equally pertinent to the Portuguese counselees. A 
study of Guimarães and colleagues (2013) indicated that the counselees appreciate aspects 
as a multidisciplinary approach, the availability of resources, and the provision of 
information, particularly when this information is adapted to their previous knowledge, or 
when it is provided in a more clear way, facilitating their understanding of that which they 
have already read or heard. Concerning the provision of information, the counselees also 
considered the previous assessment of their prior lay beliefs about the disease and the 
consultation important because that may affect their comprehension of the information. 
Moreover, the counselees have highlighted as important the establishment of a good 
professional-counselee relationship, as well as the adoption of an emphatic and open stance 
by the professional. Counselling skills such as empathy and emotional engagement are also 
mentioned as essential for an effective GC (Guimarães et al., 2013).  
 
1.5.  Reciprocal-Engagement Model of Genetic Counselling Practice as Theoretical-
Practical Underpinning 
 
It is essential to adopt a theoretical framework, based on clinical practice, which 
defines goals, essential process components, and desired effects or outcomes for GC 
(Wang et al., 2004) to develop an effective tool for GC quality evaluation by the 
counselees, because the quality of GC is deeply related to the extent that the defined goals 
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are attained, the essential process components are present during the consultation and the 
desired effects are reached and perceived by counselees (Lea, 1996).  
The Reciprocal-Engagement Model (REM) is the first proper model of the practice 
of GC. This model was developed with the goal of offering to the professionals working in 
the field a comprehensive practice model, capable of providing practice guidelines and 
quality standards for the evaluation of GC and CGS (McCarthy Veach et al., 2007). 
In its first years, GC practice was guided by models of practice from medicine, 
education and psychology, such as Carl Roger’s Client-Centered Counselling (McCarthy 
Veach et al., 2003). However, with the GC evolution, a need for a new model proper to GC 
practice has increased. Due to this demand, McCarthy Veach and colleagues (2007) 
organized a conference with the program directors of Masters in GC to develop a first 
proper model of the practice of GC – the Reciprocal-Engagement Model (REM) – based 
on the current clinical practices. According to the authors, the term ‘reciprocity’ 
emphasizes that the models’ components are not discrete, rather “they reciprocally affect 
each other, and each is necessary but not sufficient individually for influencing genetic 
counselling outcomes” (p.726). The term ‘engagement’ highlights that both professional 
and counselee have participation in this process. Together, these two words are intended to 
describe “a mutual process in which the genetic counsellor and patient participate in an 
educational exchange of genetic and biomedical information shaped by their unique 
psychosocial identities” (p. 726).    
REM is based on the current practice of GC and is formed of five tenets, seventeen 
goals, thirty-eight strategies and fourteen behaviours, which can be summarized in three 
major dimensions – education, individual attributes and relationship. The first dimension 
embodies the first tenet and associated goals, strategies and behaviours. The second 
dimension represents the third, the fourth and the fifth tenet of the model and their 
respective goals, strategies and behaviours. The last dimension represents the second tenet 
and “is at the center of the model” (McCarthy Veach et al., 2007, p. 721) because as 
McCarthy Veach and colleagues emphasize “the relationship serves as the conduit, 
providing an alliance in which the patient feels supported, cared about, connected, and 
validated” (p.725).  
The first component of REM - tenets - is associated with doctrine, and generalized 
beliefs about profession and professional responsibilities (McCarthy Veach et al., 2007). 
The five, “mutually influential” (Redlinger-Grosse et al., 2016), tenets of this model are: 
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(1) “genetics information is key”; (2) “relationship is integral to genetic counselling”; (3) 
“counselees autonomy must be supported”; (4) “counselees are resilient”; and (5) 
“counselees emotions make a difference” (p. 241). The second component - goals - is 
divided into two categories - process goals and outcome goals. Process goals are 
fundamentally the responsibility of the professionals and are concerned with “the 
conditions that must be present during genetic counselling sessions in order to achieve 
desired genetic counselling outcomes” (e.g., “genetic counsellor and patient establish a 
bond”) (McCarthy Veach et al., 2007, p. 719). Outcome goals are concerned with the 
desired outcomes in the GC and are co-constructed by the professional and the counselee 
that share responsibilities in their attainment (e.g., “patient self-esteem is maintained or 
increased”) (McCarthy Veach et al., 2007, p.721). The third component - strategies - is 
concerned with the plan or method elected by the professional in achieving those goals 
(e.g., “active listening”, McCarthy Veach et al., 2007, p.720). The fourth component - 
behaviour - is the more explicit component and it is concerned with professional actions 
(e.g., “ask questions about patient coping skills”, McCarthy Veach et al., 2007, p.720).  
The first tenet emphasizes the importance of the provision and discussion of genetics 
information to the counselees. For this model, the counselees want to receive information 
when they seek a GC service and this is one of the most unique aspects of GC (McCarthy 
Veach et al., 2007). This tenet embraces four goals, seven strategies and six behaviours 
(see Appendix B for a complete description).  
The second tenet is based on the belief that a strong professional-counselee alliance 
is fundamental to address counselee’s concerns. For this model, the GC is a “relationally 
based helping activity” whose outcomes are dependent on the quality of the professional-
counselee relationship (McCarthy Veach et al., 2007, p.721). The professional-counselee 
relationship is as important as providing genetics information to the GC outcomes 
(McCarthy Veach et al., 2007). This tenet is associated with three goals, seven strategies 
and eight behaviours (see Appendix B for a complete description).  
The third tenet lies in the belief that counselees know best what is better for them and 
therefore they can make their own decisions (McCarthy Veach et al., 2007). This is formed 
by four goals, ten strategies and four behaviours.  
The fourth tenet is in some way related to the last one because this presumes that the 
typical counselee has the strength and personal capabilities needed to deal with a GC 
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process. This tenet embraces three goals, nine strategies and one behaviour (see Appendix 
B for a complete description).  
The last tenet recognizes the relevance of the counselee’s emotions within the GC 
process. For the model, counselee’s emotions interact with and affect all GC processes and 
outcomes, for example, counselee’ emotions will influence his comprehension of 
information (McCarthy Veach et al., 2007). This tenet is compounded by three goals and 
five strategies.  
Recently, some studies have presented new evidence about the model further 
confirming its validity “(e.g., Hartmann, McCarthy Veach, MacFarlane & LeRoy, 2015; 
Redlinger-Grosse et al., 2016; Paneque et al., 2018). Hartmann and colleagues (2015) have 
shown that the goals of the model are recognized as useful and important by genetic 
counsellors. Redlinger-Grosse and colleagues (2016) have used the REM as a guiding 
framework to identify a preliminary comprehensive list of GC outcomes that can be used 
in the future for evaluating the efficiency of the GC services and/or for linking specific 
outcomes with specific aspects of GC process (Redlinger-Grosse et al., 2016). Schmidlen 
and colleagues (2018) have applied the REM to the emerging genomic counselling context 
developing a framework of counselling components and strategies, based on tenets of 
REM, for the delivery of genomic results. As aforementioned, Paneque and colleagues 
(2018) have used REM as a theoretical and practical framework to develop a scale to 
measure the quality of GC.  
 
1.6.  Study Purpose and Aims 
This study is part of a wider project developed in collaboration between the FPCEUP 
and the Centro de Genética Preditiva e Preventiva (CGPP) aimed at building a novel 
comprehensive system for assessing the quality of GC.  
In the first stage of this project, the scale for professionals’ evaluation of the quality 
of their practice was developed and validated (Costa, 2017; Paneque et al., 2018). 
Here, the main purposes were to develop and validate an analogous tool designed for 
GC quality assessment by counselees. Specific aims of this study were (a) to develop the 
scale, (b) to pre-test the scale and (c) to examine its structure and (d) to evaluate its 
psychometric properties.  
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This study intends to contribute to the existent research on evaluation of GC, in 
general, and counselees’ evaluation of GC quality, in particular, by providing the first scale 
theoretically and methodologically sound to the GC quality evaluation by the counselees.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
17 
 
II. Methods 
2.1.  Scale Development 
The scale development was mainly based on the previously developed scale for 
professionals to assess the quality of GC (Paneque et al., 2018). The main findings of the 
literature review about counselee’s perspectives of the GC were also used to develop the 
scale dimensions and items, aiming to improve the scope of the scale and enhance its 
content validity. Integrating the literature review with the professionals scale items’ 
content and wording, and structure, a first draft of the present scale with fifty-two items 
was developed. 
 The scale was conceptualized as containing five different dimensions. The 
professional scale items’ assessing reflexive practice and professionalism were not 
included in the present scale. Based on the literature review, five new items were added to 
this scale. Item 3.9. that is concerned with the counselee’s evaluation of the professional 
perceived expertise. Item 4.5. that is related to effect of GC on the improvement of family 
communication of genetics information. Item 4.8. that is concerned with the extent to 
which the counselee’s expectations were met. Item 5.9. that aims to evaluate whether 
tailored family care was provided by clinical genetics services. Item 5.10. that assesses the 
clinical genetics services openness to establish long-term relationships. The addition of 
these items to the scale was supported by the fact of these items could be harmoniously 
integrated into the scale structure without compromising its internal coherence.  
The majority of the items were worded in a positive direction, with the exception of 
the items 3.4., 3.5. and 3.6.. Negatively phrased items were avoided, as well as biased, 
leading and/or double-barreled items (Leavy, 2017). The items wording and content were 
verified by three different researchers that examined their adequacy, compared the two 
scales and made suggestions to increase their appropriateness and comparability. One of 
the researchers has a large clinical experience in the field of GC and another is an expert in 
questionnaire design.  
A five-point Likert-type response scale was used ranging from 1 (strongly disagree) 
to 5 (strongly agree) (3 = agree), with higher scores indicating higher levels of perceived 
quality. An additional option - “not applicable” - was added to the scale given that some 
items may not apply to certain GC types of consultation due to its nature or to the specific 
18 
 
clinical setting where the consultation took place. For example, in a consultation to 
communicate the genetic test result the professional would not be expected to ask 
questions related to counselee personal or familial background because this is usually 
content of the previous consultations.  
Paper-and-pencil version and an online version of the scale were created to facilitate 
the data collection. 
 
2.2.  Pre-testing: Face and Content Validity of the Scale 
A pre-testing is an important step in the process of developing a new scale because it 
enables the analysis of the suitability and the wording of the items, as well as, the scale 
face validity and its ability to gauge the construct under investigation (Leavy, 2017).  
For pre-testing the scale, firstly, one of the researchers who participated in the 
professionals’ scale development was interviewed for feedback and his/her suggestions 
incorporated.  
Secondly, a sample of adults who had had a GC consultation between June and 
August of 2018 were recruited from CGPP. The recruitment of the pre-test sample was 
mediated by a professional working at CGPP. Given the reduced number of counselees 
available in this service during that period, all adults who had a GC consultation at CGPP 
in those months were invited to collaborate in the scale’s pretesting. They also received a 
participation information sheet about the study and written informed consent and were 
informed that the main aim of their participation was to evaluate the quality of the scale 
rather than to assess the performance of the professional or the consultation quality. Seven 
counselees, 4 men and 3 women, with ages ranging from 18 to 68 (M = 32.71, SD = 20.51) 
agreed to answer the scale. A cognitive interview was then conducted with 5 of those 
participants. 
 The more common application of cognitive interview, which consists of the 
administration of the draft scale followed by the collection of verbal reports about the 
understanding of the scale items and response scale, was used (Beatty & Willis, 2007). The 
verbal material was elicited through a flexible semi-structured interview protocol created to 
the effect and based on the verbal probing method (Willis, 2015) (see Appendix C for a 
detailed description of the cognitive probes used). This method was chosen for being less 
burdening to the participants, interfering less on the answer process and being capable of 
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eliciting information stored in short-term memory (Beatty & Willis, 2007; Willis, 2015). 
With regard to the timing of the probe, a hybrid approach proposed by Willis (2015) was 
adopted, which consisted of a retrospective probing after each dimension of the scale. 
Cognitive interviews were conducted face to face at CGPP. The interviews duration 
ranged between fifteen and thirty minutes. Participants answered some verbal probes to 
explore whether items were understood as expected and to test their relevance and 
ambiguity. During and after the interviews, the interviewer took written notes about the 
participants’ verbatim. The notes were analyzed following the guidelines suggested by 
Willis (2015). 
As a result of the cognitive interviewing analysis, six items were re-worded to 
increase their clarity and ease their understanding (see Appendix D for a detailed 
description of the modifications in the items). The decision to re-word some items was 
discussed with the two experts above mentioned until consensus was reached. The scale 
graphic design was also modified in order to improve its visual appearance and clarify the 
correct usage of the response option – ‘not applicable’. In addition, an example was added 
to the scale instructions aiming to enhance the comprehension of that response option 
meaning.   
 
2.3.  Scale Description 
The scale validation version comprised fifty-two items organized into five 
conceptual dimensions that generally corresponded to those in the instrument for quality 
assessment by professionals (Costa, 2017; Paneque et al., 2018): (a) ‘genetic education’; 
(b) ‘counselee’s individual attributes’; (c) ‘relationship and communication issues’; (d) 
‘potential effects’; and (e) ‘services provision’. 
The ‘genetic education’ dimension had twelve items (from 1.1. to 1.12) (e.g., “O 
profissional forneceu-me informações sobre os testes genéticos, como por exemplo: os 
procedimentos, os possíveis resultados e limitações”). The ‘counselee’s individual 
attributes’ comprised eleven items (from 2.1. to 2.11.) (e.g., “O profissional perguntou-me 
e compreendeu o(s) motivo(s) do meu pedido de consulta). The ‘relationship and 
communication issues’ dimension included nine items (from 3.1. to 3.9.) (e.g., “O 
profissional não emitiu juízos de valor relativamente aos meus pontos de vista”). The 
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‘potential effects’ dimension comprised ten items (from 4.1. to 4.10.) (e.g., “Sinto-me mais 
capacitado para comunicar com os meus familiares acerca desta doença e/ou o seu risco”). 
The ‘services provision’ dimension had ten items (from 5.1. to 5.10.) (e.g., “A duração da 
consulta foi adequada”).  
The scale comprised also three sociodemographic questions (age, gender and clinical 
setting of the GC consultation).  
The average time needed to answer the scale ranged between five to ten minutes.    
 
2.4.  Procedure 
After approval from FPCEUP Ethics Committee was obtained, all main national 
genetics services
4
 were invited to take part in this study through the management of the 
participants’ recruitment process.  
An email was sent to each director of national CGS and/or other professionals 
working in the services, inviting them to participate and describing the study context, 
goals, methodology and means of dissemination of the results. The email, for ethical 
purposes, also requested the nomination of a professional per service responsible for the 
study to ensure the anonymity of both the professionals and counselees. The eligibility 
criteria (had had a GC consultation, older than eighteen years, able to speak and read in 
Portuguese and provide their written informed consent) and exclusion criteria (having a 
cognitive disorder affecting consent ability) were indicated. As well as the participation 
options: (a) answer the online version through Survey Monkey (a survey software, Palo 
Alto, CA, USA); (b) answer at home and send the scale by postal service; and (c) answer 
in the service and deliver the scale to the administrative staff. Although the process of data 
collection has varied across the services, some general recommendations in this regard 
were given, namely: (a) counselees should be approached individually and after their GC 
consultation, and (b) should be informed that their answers would be kept confidential, (c) 
would not be shared with the professional who provided the consultation, and (d) at this 
stage would not be used for evaluating the performance of the service neither the 
                                                             
4
Presently, there are seven CGS in Portugal and other ten hospital services which offer GC consultations 
(Costa, 2017).   
21 
 
professional. The contents of the scale and study objectives should be explained to the 
counselees as well.  
A study protocol, the scale’s validation version, a participant information sheet and 
the consent forms were attached to this email. Later, the same files were sent in paper 
format to the services that had answered positively to the invitation. 
 
2.5.  Ethical Considerations 
The study was approved by FPCEUP Ethics Committee. All procedures performed 
were in accordance with the ethical standards of this institutional research committee and 
with the 1964 Helsinki declaration and its later amendments. Written informed consent 
was obtained from all participants. Participation was anonymous, confidential and 
voluntary, and the participants did not earn any recompense for participation. The collected 
answers were pseudonymised through a codification technique and the personal data 
(gender, age or GC consultation clinical setting) were encrypted in a database using 
numeric codes.  
 
2.6.  Participants 
The sample of the study is formed by individuals who had a GC consultation at the 
following national CGS: (a) CGPP; (b) Centro Hospitalar e Universitário de Coimbra; (c) 
Centro Hospitalar Universitário Lisboa Norte and (d) Hospital Divino Espírito Santo 
(Azores), between September of 2018 and May of the current year. The sample comprises 
107 participants, 73 female and 32 male (see Table 3), who were selected using the 
convenience sampling method, a non-probabilistic sampling process (Marôco, 2007). The 
age of the participants ranged from 18 to 75 (M = 40.5; SD = 16.28). In relation to the 
clinical setting, the following GC clinical settings were included: prenatal (n = 3), 
oncogenetic (n = 18), genetic diagnosis (n = 32) and predictive test (n = 54). For ethical 
reasons, those potential participants who were approached to participate and decided not to 
take part in the study were not asked to justify their choice. The number of consultations 
per service during this period was not obtained for ethical reasons too, so it is not possible 
to report accurate participation rates.  
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Table 3 
Sample characterization 
 Prenatal  Oncogenetic Genetic 
Diagnosis 
Predictive Test Total 
N 3 (2.8%) 18 (16.8%) 32 (29.9%) 54 (50.5%) 107 
Gender 
Male 
 
- 
 
2 (11.1%) 
 
13 (40.6%) 
 
17 (31.5%) 
 
32 
Female 3 (100%) 14 (77.8%) 19 (59.4%) 37 (68.5%) 73 
Age 
18-29 
 
- 
 
2 (11.1%) 
 
6 (18.7%) 
 
20 (37%) 
 
28 
30-39 2 (67%) 3 (16.67%) 11 (34.4%) 10 (18.5%) 26 
40-49 1 (33%) 2 (11.1%) 11 (34.4%) 9 (16.7%) 23 
50-59 - 4 (22.2%) 1 (3.1%) 3 (5.5%) 8 
60-69 - 4 (22.2%) - 7 (13%) 11 
70+ - 3 (16.67%) - 4 (7.4%) 7 
Note. Presented percentages are valid percentages. 
 
2.7.  Data Analysis  
All raw-data were entered into IBM Statistical Package for the Social Sciences 25.0. 
for analysis. Descriptive statistics (item level) was calculated to analyze possible data entry 
error and examine items sensitivity.  
Structure of the scale was examined using principal component analysis (PCA). PCA 
was conducted separately for each dimension of the scale. Given this is a new instrument, 
eigenvalues (equal or above 1) were used as the criterion for extraction of components. 
Solution rotation was performed in order to simplify and clarify data structure, and 
increase the components interpretability (Bryman & Cramer, 2003; Field, 2013; 
Tabachnick & Fidell, 2012). Direct oblimin oblique rotation was used because attending to 
the scale’s theoretical background it was expected that components would be correlated 
(Tabachnick & Fidell, 2012).  Components retention followed Kaiser’s criteria (Field, 
2013). Graphical scree test was used in complement to verify the best component solution 
(Tabachnick & Fidell, 2012). Items selection and retention was decided based on 
empirical, theoretical and clinical criteria. Empirically, the following criteria were used: (a) 
communalities below .40, (b) component loadings below .30; and (c) items that cross-
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loaded in more than one component with a difference between .10 and .15 (Field, 2013). 
The theoretical consistency of the components was analyzed using the REM and discussed 
by the group of researchers above mentioned. The items clinical relevance was also 
discussed by the group of researchers until consensus was reached. The clinical relevance 
was elected as an overweight criterion on items selection and retention because some items 
are fundamental quality indicators, which cannot be discarded in quality evaluation 
regardless of statistical results. Interpretation and naming of the components (following 
oblique rotation and items selection) were based primarily on the components identified in 
the scale for professionals (Costa, 2017; Paneque et al., 2018) and the REM of practice of 
GC (McCarthy Veach et al., 2007).  
 Prior to the PCA, some preliminary analyses were performed. Missing data analysis 
was performed using descriptive statistics of each item. Sample size adequacy was tested 
using the Kaiser-Meyer-Olkin statistic (KMO). KMO values equal to or greater than .5 
were considered acceptable (Field, 2013). Bartlett’s test of sphericity was used to test 
whether the original correlation matrix was an identity matrix (Field, 2013). Correlation 
matrix was observed to look for multicollinearity and singularity problems. The cut-off 
value of .90 was adopted to analyze the correlation values (Field, 2013). 
Pearson’s correlation among scale dimensions was used to assess construct validity 
and understand better the relationships among the dimensions. For calculating the 
correlations, a composite dimension mean was created for each dimension, based on the 
scores of items which constitute each dimension. All items were equally weighted in this 
mean. The strength of all correlations was evaluated based on prevailing statistical 
standards (Bryman & Cramer, 2003).  
Reliability was assessed using an internal consistency measure - Cronbach’s alpha 
coefficient - for each component and dimension. Cronbach’s alpha values between .70 and 
.80 were considered acceptable. Corrected item-total correlations and Cronbach’s alpha if 
item deleted were also calculated in order to examine the contribution of individual items 
to each dimension. Items with an item-total correlation equal to or higher than .3 were 
considered as meaningful to the dimension. 
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III.  Results 
 
3.1.  Preliminary Analyses  
There were no items with 5% or more missing data (see Appendix F for detailed 
results). The KMO measure of all dimensions ranged from .69 to .89, demonstrating the 
adequacy of the sample size for PCA. The item measures of sampling adequacy ranged 
between .51 and .95, further confirming the sample size adequacy. The Bartlett’s test of 
sphericity was significant and yielded adequate values for all dimensions [χ²(10) = 202.17, 
p <.001; χ²(21) = 174.13, p < .001; χ²(45) = 549.33, p < .001; χ²(28) = 481.36, p < .001; 
χ²(45) = 632.15,   p < .001; χ²(36) = 388.52, p < .001 for ‘counselee’s education’, 
‘counselee’s knowledge and understanding’, ‘counselee’s individual attributes’, 
‘relationship and communication issues’, ‘potential effects’ and ‘services provision’ 
dimensions, respectively]. All items presented correlations below .90 (Field, 2013; 
Tabachnick & Fidell, 2012).  
 
3.2.  Principal Component Analysis  
3.2.1.  ‘Genetic Education’ Dimension.  
Together, the set of items that were expected to assess the ‘genetic education 
dimension’ did not present sufficient statistical robustness, neither satisfactory theoretical-
practical consistency. Therefore following clinical and theoretical criteria (McCarthy 
Veach et al., 2007), these items were reorganized into two distinct dimensions: 
‘counselee’s education’ (items 1.2., 1.3., 1.4., 1.5. and 1.12.) and ‘counselee’s knowledge 
and understanding’ (items 1.1., 1.6., 1.7., 1.8., 1.9., 1.10. and 1.11.). PCA was performed 
for each dimension separately.   
 
3.2.1.1. ‘Counselee’s Education’ Dimension.  
PCA for ‘counselee’s education’ items yielded a two-component solution explaining 
74.7% of the total variance (see Table 4 for detailed results).  
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The first component, with three items, was defined as ‘to provide biomedical 
information’ because the three items are related to the provision of information related to 
the disease and test. Example items included, “O profissional forneceu-me informações 
sobre a doença, como por exemplo: os sintomas, a idade e o modo de início, o prognóstico 
e os tratamentos possíveis” (item 1.2.). This component accounted for 54.3% of the 
variance, corresponding to an eigenvalue of 2.71. The component loadings ranged between 
.77 and .97 (M = .88).  
The second component, with two items, was labelled as ‘to identify additional 
resources’ because both items are related to the provision of information about additional 
resources or sources of support such as patient associations. Example items included, “O 
profissional forneceu-me informações sobre possíveis fontes de apoio, como por exemplo: 
associações de doentes, instituições de apoio social e outras redes sociais de apoio” (item 
1.5.). This component accounted for 20.4% of the variance, corresponding to an eigenvalue 
of 1.02. The component loadings were of .77 (1.5.) and .86 (1.6.).  
The component ‘to provide biomedical information’ presented an acceptable internal 
consistency (Field, 2013) unlike the component ‘to identify additional resources’ which 
presented a lower internal consistency. Nevertheless, this component was retained given its 
theoretical consistency and the relevance of its items as fundamental quality indicators of 
GC. 
 
Table 4 
Component loadings after rotation and items selection of the ‘counselee’s education’ dimension 
 Component loadings 
Items C1 C2 h
2
 
1.2. Information about the disease. .90  .81 
1.3. Information about the genetic test.  .97  .89 
1.4. Information about reproductive alternatives.  .86 .71 
1.5. Information about support sources and resources (e.g., patient 
associations). 
 .77 .65 
1.12. Confidentially.  .77  .68 
Total variance explained (%) 54.3% 20.4%  
Eigenvalue following rotation 2.71 1.02  
Cronbach’s alpha .86 .52  
Extraction method: Principal component analysis  
Rotation method: Oblimin with Kaiser normalization 
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Rotation converged in 4 iterations    
Note. As a consequence of the existence of missing values in one or more scales, N = 105. Values were obtained from 
pattern matrix table. Items which were retained in the component of that column are in boldface. h2 = Final communality 
estimate; C1 = Component one; C2 = Component two.  
 
 
3.2.1.2. ‘Counselee’s Knowledge and Understanding’ Dimension.  
PCA for ‘counselee’s knowledge and understanding’ items yielded a two-component 
solution explaining 57.3% of the total variance (see Table 5 for detailed results).  
The first component, with four items, was labelled as ‘meaningful understanding’ 
because the four items which loaded on this component are related to the professional 
strategies to actively engage the counselee in the consultation, to facilitate the counselee 
meaningful understanding of information and to ensure the usefulness of the information 
for the counselee. Example items included, “O profissional procurou saber se a informação 
fornecida foi importante para mim” (item 1.9.). This component accounted for 38.2% of 
the variance, corresponding to an eigenvalue of 2.67. The item 1.1. presented a 
communality lower than the cut-off value of .40 (.12) but it was maintained due to its 
relevance as a fundamental quality indicator of GC. The remaining component loadings 
ranged between .75 and .88 (M = .82).  
The second component, with three items, was defined as ‘strategies to facilitate 
counselee’s understanding’ because all of its items represent strategies to facilitate 
counselee’s understanding of the information and to assess counselee’s understanding of 
information. Example items included, “O profissional pediu-me para resumir, pelas minhas 
próprias palavras, as informações que recebi” (item 1.11.). This component accounted for 
19.1% of the variance, corresponding to an eigenvalue of 1.34. The item 1.6. cross-loaded 
on both components but it was included in this component, with which it is conceptually 
more related. The component loadings ranged between of .48 and .80 (M = .68).  
As a consequence of the 1.1. and 1.6. items retention both components presented a 
lower Cronbach’s alpha (.59 and .56, respectively). 
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Table 5 
Component loadings after rotation and items selection of the ‘counselee’s knowledge and understanding’ 
dimension 
 Component loadings 
Items C1 C2 h
2
 
1.1. Counselee’s expectations. .34  .12 
1.6. Questions about counselee’s understanding. .51 .48 .58 
1.7. Language clarity.  .88  .75 
1.8. Doubts. .83  .67 
1.9. Information usefulness.  .75  .65 
1.10. Audiovisual and didactic materials.  .76 .55 
1.11. Resume information provided.  .80 .69 
Total variance explained (%) 38.2 19.1  
Eigenvalue following rotation 2.67 1.34  
Cronbach’s alpha .59 .56  
Extraction method: Principal component analysis  
Rotation method: Oblimin with Kaiser normalization 
   
Rotation converged in 5 iterations    
Note. As a consequence of the existence of missing values in one or more scales, N = 105. Values were obtained from 
pattern matrix table. Items which were retained in the component of that column are in boldface. h2 = Final communality 
estimate; C1 = Component one; C2 = Component two. 
 
3.2.2.  ‘Counselee’s Individual Attributes’ Dimension.  
A first PCA, the item 2.3. was eliminated because it presented a lower communality 
(.29) and it was not considered an indispensable quality indicator in the clinical practice 
(see Table 6 for detailed results).  
A second PCA, without this item, resulted in two components that explained in 
combination 62.7% of the total variance (see Table 6 for detailed results).  
The first component, with seven items, was defined as ‘emotional experience, 
motivations and decision-making support’ because some of its items are related to 
counselee’s emotions, and other items represent motivations to pursue with the test and 
strategies used by professional to support the decision-making (e.g., to explore the 
potential life changes caused by genetic test). Example items included, “O profissional 
ajudou-me a refletir sobre os prós e os contras das minhas opções” (item 2.8.) and 
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“Durante a consulta tive espaço para exprimir as minhas emoções” (item 2.6.). This 
component accounted for 50.6% of the variance, corresponding to an eigenvalue of 5.06. 
The item 2.11. presented a lower communality (.36) but it was retained for this component 
given its clinical relevance. The component loadings ranged between .40 and .91 (M = 
.71).  
The second component is formed of three items that together explained 12.1% of the 
variance, corresponding to an eigenvalue of 1.21. The retained items are all related to the 
adequacy of consultation to the counselee characteristics and needs, therefore the 
component was labelled as ‘counselee-centred care’. Example items included, “A consulta 
foi organizada de forma a responder às minhas necessidades” (item 2.1.). The item 2.1. 
cross-loaded on both components, but it was retained for this factor, as it is clearly more 
pertinent to an expression of the adequacy of consultation to the counselee characteristics 
rather than emotional experience and motivations and support to the decision-making, and 
given its higher loading on this component (.51). The remaining component loadings were 
of .84 (item 2.2.) and .90 (item 2.10.).  
Both components presented acceptable values of internal consistency (.85 and .75, 
respectively) (see Table 6).  
 
Table 6 
Component loadings after rotation and items selection of the ‘counselee’s individual attributes’ dimension 
 Component loadings 
Items C1 C2 h
2
 
2.1. Consultation meeting my needs. .39 .51 .58 
2.2. Counselee’s reason for consultation.  .84 .76 
2.3. Values and beliefs related to genetic counselling (e.g., religion). - - .29 
2.4. How counselees and their families cope with the disease. .63  .42 
2.5. Counselee’s emotional reactions.   .87  .64 
2.6. Expression of emotions during the consultation. .73  .66 
2.7. Life changes caused by genetic test.  .91  .77 
2.8.  Genetic test pros and cons. .87  .74 
2.9. Feeling secure during the consultation. .55  .62 
2.10. Informed consent.  .90 .72 
2.11. Next steps after the consultation. .40  .36 
Total variance explained (%) 50.6 12.1  
Eigenvalue following rotation 5.06 1.21  
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Note. As a consequence of the existence of missing values in one or more scales, N = 105. Values were obtained from 
pattern matrix table. Items which were retained in the component of that column are in boldface. h2 = Final communality 
estimate; C1 = Component one; C2 = Component two. 
 
3.2.3.  ‘Relationship and Communication Issues’ Dimension.  
After a first PCA, item 3.8. was eliminated because it cross-loaded on both 
components and it was not considered an indispensable quality indicator from a clinical 
perspective. Furthermore, as the item 3.2. also measures active listening, its elimination did 
not mean a loss of a quality indicator.  
A second PCA, without item 3.8., resulted in two components that explained in 
combination 72.3% of the total variance (see Table 7 for detailed results).  
The first component, with five items, was labelled as ‘counselee-professional 
relationship’ because all items are related to counselee’s perception about how 
professionals interact with them. Example items included, “O profissional ouviu-me com 
atenção e interesse” (item 3.2.). This component accounted for 49.7% of the variance, 
corresponding to an eigenvalue of 3.98. The component loadings ranged between .73 and 
.93 (M = .81).  
The second component, with three items, was defined as ‘counselee’s acceptance’ 
given that all of these items are related to the professional respect by the counselee values, 
decisions and perspectives. Example items included, “O profissional evitou transparecer o 
seu próprio ponto de vista quando discutimos as minhas opções” (item 3.5.). This 
component accounted for 22.6% of the variance, corresponding to an eigenvalue of 1.80. 
The component loadings ranged between .88 and .91 (M = .89). 
Both components presented acceptable values of internal consistency (.86 and .88, 
respectively).  
 
 
 
Cronbach’s alpha .87 .75  
Extraction method: Principal component analysis  
Rotation method: Oblimin with Kaiser normalization 
   
Rotation converged in 6 iterations    
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Table 7 
Component loadings after rotation and items selection of the ‘relationship and communication issues’ 
dimension 
Note. As a consequence of the existence of missing values in one or more scales, N = 105. Values were obtained from 
pattern matrix table. Items which were retained in the component of that column are in boldface. h2 = Final communality 
estimate; C1 = Component one; C2 = Component two. 
 
3.2.4.  ‘Potential Effects’ Dimension.  
PCA for ‘potential effects’ items yielded a two-component solution explaining 
68.3% of the total variance.  
The first component, with five items, was labelled as ‘satisfaction’ because the 
majority of its items are related to counselees’ satisfaction and the meeting of their 
expectations. Example items included, “O que eu esperava desta consulta concretizou-se” 
(item 4.8.). This component accounted for 55.7% of the variance, corresponding to an 
eigenvalue of 5.57. The component loadings ranged between .63 and .85 (M = .79).  
The second component, with five items, was defined as ‘empowerment’, given that 
all of its items are related to an improvement of counselee’s abilities to cope, communicate 
and perceive or think about their disease. Example items included, “Sinto-me mais capaz 
Component loadings  
Items C1 C2 h
2
 
3.1. Counselee’s acceptance. .84  .73 
3.2.  Active listening 1. .93  .86 
3.3. Counselee-centered consultation. .76  .56 
3.4. Nondirectiveness 1.  .88 .83 
3.5. Nondirectiveness 2.  .91 .85 
3.6.  Nondirectiveness 3.  .88 .75 
3.7. Counselee-professional communication. .77  .70 
3.8. Active listening 2. .54 .41 .62 
3.9. Professional’s expertise. .73  .52 
Total variance explained (%) 49.7 22.6  
Eigenvalue following rotation 3.98 1.80  
Cronbach’s alpha .86 .88  
Extraction method: Principal component analysis  
Rotation method: Oblimin with Kaiser normalization 
   
Rotation converged in 4 iterations    
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de utilizar os apoios e os recursos existentes para satisfazer as minhas necessidades” (item 
4.3.). This component accounted for 12.6% of the variance, corresponding to an eigenvalue 
of 1.26. The component loadings ranged between .53 and .94 (M = .75).  
The Cronbach’s alpha for these components is .89 and .85, respectively (see Table 8) 
reflecting an acceptable internal consistency.  
 
 
Table 8 
Component loadings after rotation and items selection of the ‘Potential Effects’ dimension 
Note. As a consequence of the existence of missing values in one or more scales, N = 103. Values were obtained from 
pattern matrix table. Items which were retained in the component of that column are in boldface. h2 = Final communality 
estimate; C1 = Component one; C2 = Component two. 
 
3.2.5. ‘Services Provision’ Dimension.  
In a first PCA, item 5.5. was eliminated because it cross-loaded on both components 
and clinically was not considered an indispensable quality indicator. Moreover, as the item 
Component loadings  
Items C1 C2 h
2
 
4.1. Disease knowledge improvement.  .63  .73 
4.2.  Doubts decrease. .77  .65 
4.3. Empowerment 1.  .64 .45 
4.4. Coping with disease and/or risk.  .84 .71 
4.5. Empowerment 2.  .79 .69 
4.6. New perspectives.  .94 .76 
4.7. Counselee-professional relationship.    .53 .58 
4.8. Expectations meeting. .79  .79 
4.9.  Satisfaction 1. .92  .85 
4.10. Satisfaction 2. .85  .60 
Total variance explained (%) 55.7 12.6  
Eigenvalue following rotation 5.57 1.26  
Cronbach’s alpha .89 .85  
Extraction method: Principal component analysis 
Rotation method: Oblimin with Kaiser normalization 
   
Rotation converged in 8 iteration    
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1.10. also measures the use of audiovisual and didactic material, this elimination did not 
mean a real loss of a quality indicator.  
A second PCA yielded a two-component solution, however, given the eigenvalue of 
the third component (.99) it was decided to repeat the analysis but forcing the program to 
extract three components. This analysis resulted in three components that explained in 
combination 69.9% of the total variance (see Table 9 for detailed results). 
The first component, with five items, was defined as ‘services organization’ because 
all of its items are related to services characteristics that reflect its general organization, 
such as the existence of a multidisciplinary team. Example items included, “Um aspeto 
importante deste serviço é a existência de uma equipa de profissionais de áreas distintas” 
(item 5.8.). This component accounted for 38.7% of the variance, corresponding to an 
eigenvalue of 3.48. The component loadings ranged between .63 and .87 (M = .77).  
The second component, with two items, was labelled as ‘preparation of the counselee 
for the consultation’ given that both items represent services strategies to prepare the 
counselee for the consultations. Example items included, “Fui previamente contactado 
telefonicamente para preparar a consulta” (item 5.2.). This component accounted for 20.2% 
of the variance, corresponding to an eigenvalue of 1.82. The component loading of both 
items was .96.  
Cronbach’s alphas of .80 and .93 for both components indicate that these have a 
good internal consistency (Field, 2013).  
The third component, with two items, was named as ‘time management’ because 
both items are related to time aspects, such as the waiting time for the test result 
communication. Example items included, “O tempo de espera pela comunicação dos 
resultados foi o previsto” (item 5.7.). This component accounted for 11% of the variance, 
corresponding to an eigenvalue of .99. Item 5.4 cross-loaded on all components but it was 
decided to retain this item on this component, with which it is more clearly related in a 
conceptual perspective, therefore facilitating the component interpretation. The component 
loadings were of .35 (item 5.4.) and .94 (item 5.7.). Given the clinical relevance of these 
two items and its theoretical consistency together it was decided to retain this component 
in spite of its lower eigenvalue and Cronbach’s alpha (.35). 
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Table 9 
Component loadings after rotation and items selection of the ‘services provision’ dimension 
Note. As a consequence of the existence of missing values in one or more scales, N = 102. Values were obtained from 
pattern matrix table. Items which were retained in the component of that column are in boldface. h2 = Final communality 
estimate; C1 = Component one; C2 = Component two; C3 = Component three. 
 
3.3.  Construct Validity 
In general, all dimensions were significantly (p < .001), positively and moderately 
(.42 ≤ r of all dimensions ≤ .74) correlated with each other as expected, providing evidence 
of construct validity (see Table 10 for detailed results). A strong correlation was found 
between the ‘counselee’s individual attributes’ dimension and the ‘counselee’s knowledge 
and understanding’ dimension (r = .74). A similar correlation was found between 
‘counselee’s individual attributes’ dimension and ‘potential effects’ dimension     (r = .73). 
However, correlations with the ‘services provision’ dimension were not as strong (.42 ≤ r 
of ‘services provision dimension’ with the remaining dimensions ≤ .49), with the exception 
of the ‘potential effects’ dimension with which it had a Pearson’s r of .61. 
 
 Component loadings  
Items C1 C2 C3 h
2 
5.1. Consultation duration. .77   .62 
5.2. Consultation preparation 1.  .96  .91 
5.3. Consultation preparation 2.   .96  .93 
5.4. Time management 1. .46 .15 .35 .46 
5.5. Audiovisual and didactic materials.   .46 .39 .42 
5.6. Privacity. .79   .70 
5.7. Time management 2.   .94 .88 
5.8. Clinical team muldisciplinarity. .87   .72 
5.9. Openness for other family members. .63   .48 
5.10. Openness for future contacts. .79   .60 
Total variance explained (%) 38.7 20.2 11  
Eigenvalue following rotation 3.48 1.82 .99  
Cronbach’s alpha .80 .93 .35  
Extraction method: Principal component analysis  
Rotation method: Oblimin with Kaiser normalization 
   
Rotation converged in 5 iterations     
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Table 10 
Correlations between the scale dimensions  
 1 2 3 4 5 6 
1. Counselee’s education       
2. Counselee’s 
understanding and 
knowledge 
.67**      
3. Counselee’s individual 
attributes 
.67** .74**     
4. Relationship and 
communication issues 
.49** .55** .62**    
5. Potential effects .49** .69** .73** .65**   
6. Services provision .42** .53** .49** .48** .61**  
Note.   
**Correlation is significant at the .01 level. 
 
3.4.  Reliability 
Almost all dimensions presented acceptable levels of internal consistency in this 
sample, presenting values equal or higher than the reference values of .70 and .80 (.70 ≤ α 
of all dimensions ≤ .90), with the exception of the dimension ‘counselee’s understanding 
and knowledge’ which presented an alpha value of .60 (see Appendix E for detailed 
results). In general, the deletion of the majority of items did not appreciably improve the 
internal consistency and almost all items have an item-total correlation above .3, with the 
exception of items 1.1. and 1.10.. Even though these items contribute to decreasing the 
internal consistency of the dimension, they were not eliminated given their clinical 
relevance as fundamental quality indicators of a GC consultation.  
 
 
3.5.  Items Sensitivity  
In general, the items presented absolute values of skewness and kurtosis above |1|, 
indicating the presence of a non-normal distribution (see Appendix F for detailed results). 
The analysis of the distribution of the responses for each item revealed the presence of a 
ceiling effect (see Appendix G for detailed results).  
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IV. Discussion 
The present study was aimed at developing and validating a new multidimensional 
scale to assess counselees’ evaluation of GC quality, thereby fulfilling a demand of the 
professionals and CGS.  
On the whole, results indicated that this scale is a valid and reliable tool. Current 
findings are in general aligned with the components found in scale for professionals and 
REM components (Costa, 2017; Paneque et al., 2018; McCarthy Veach et al., 2007). New, 
however, is the finding of the components - ‘counselee-centred care’ and ‘time 
management’.  
The emergence of the component ‘counselee-centred care’ is in line with the 
international guidelines and numerous studies in the field of healthcare which emphasize 
the patient-centred care as a quality standard in healthcare and a fundamental dimension of 
the broader concept of high-quality healthcare (e.g., Institute of Medicine [IOM], 2001). In 
addition, the identification of this component highlights the value that the counselees place 
on receiving care that is respectful of and responsive to their needs, preferences and values 
(IOM, 2001). Which is consistent with much of the counselees literature reviewed in the 
first chapter (Bernhardt et al., 2000; Costal Tirado et al., 2017; Paneque et al., 2015a; 
Skirton, 2001). The identification of ‘time management’ is also aligned with the literature 
about the evaluation of the quality of healthcare (IOM, 2001; Stalk & Hout, 1990). 
According to IOM (2001), the “timeliness” or time management is an important dimension 
of quality of healthcare. For Stalk and Hout (1990) time management is not only a 
competitive advantage for a healthcare service but also an essential aspect for the patient 
since timing might influence the treatment prescribed and ultimately even the patient 
survival (Stalk & Hout, 1990). This is also congruent with the counselees literature 
reviewed in the first chapter (Bernhardt et al., 2000; Guimarães et al., 2013; McAllister et 
al., 2008b; Paneque et al., 2012).  
Confirming the importance of the psychosocial factors in the GC, components such 
as ‘emotional experience, motivations and decision-making support’, ‘counselee-centred 
care’, ‘counselee-professional relationship’ and ‘counselee’s acceptance’ were identified. 
Moreover, components such as ‘meaningful understanding’ and ‘strategies to facilitate 
counselee’s understanding’ were found. Further confirming the value that the counselees 
attribute to receive personalized care and be actively involved in the GC process. These 
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findings further support the validity of the scale, as they are in accordance with published 
studies about the counselees’ perspective of GC (e.g.,, Bernhardt et al., 2000; Guimarães et 
al., 2013; MacLeod et al., 2002). 
Providing further evidence of the validity of the scale, values of total variance 
explained of the components, as well as component loadings, and components reliability 
were, in general, all good. Nevertheless, the performance of the items 1.1. and 5.4., and the 
components ‘to identify additional resources’, ‘meaningful understanding’, ‘strategies to 
facilitate counselee’s understanding’ and ‘time management’ should be further examined 
in future studies.  
At item level, the five new items introduced in this scale demonstrated adequate 
functioning, further confirming this adequacy as valuable quality indicators for counselees. 
The construct validity of the scale was also supported in the correlation matrix 
analysis. The dimensions are significantly, positively and moderately correlated 
demonstrating that they are related but separated toward measuring different dimensions of 
a single global construct – GC quality. Regarding the correlations found, the stronger 
correlation between ‘counselee’s individual attributes’ and ‘counselee’s knowledge and 
understanding’(r = .74) is congruent with the findings reported in previous studies (e.g., 
Guimarães et al., 2013; Macleod et al., 2002; McCarthy Veach et al., 2007). Supporting the 
association between the adaptation of the information to the counselees’ needs, 
expectations, personal and interpersonal characteristics, and previous knowledge and the 
counselee’s understanding. The correlation between ‘counselee’s individual attributes’ and 
‘potential effects’ (r = .73) is also convergent with the conclusions of Guimarães and 
colleagues (2013) as well as with the findings previously reported on the general medical 
literature (e.g., Internacional Alliance of Patients’ Organizations, 2007). Further 
confirming the association between a more personalized and counselee-centred approach 
and the patient’s health outcomes and levels of satisfaction. The lower correlations 
presented by the dimension ‘services provision’ were also expected because in contrast to 
the other dimensions the ‘services provision’ is not originally part of REM. As well as the 
moderate correlation between the ‘services provision’ dimension and ‘potential effects’ 
dimension is not surprising (r = .61). Given that other authors, such as McAllister and 
colleagues (2008) have already claimed that some attributes related to services provision 
may contribute to maximizing counselees’ benefits and outcomes. This correlation, in turn, 
demonstrates the pertinence of the integration of this dimension in this scale. 
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In terms of reliability, the scale presented acceptable values of internal consistency 
(.70 ≤ α of all dimensions ≤ .90), with the exception of the dimension ‘counselee’s 
understanding and knowledge’ (.60). According to Nunnally (1978), this can be also 
considered as an acceptable value for first reliability analysis.  
Regarding the items sensitivity, the results are consistent with findings reported 
previously in the validation study of the scale for professionals (Costa, 2017). Considering 
the results previously reported with similar counselee’s samples (Bleiker et al., 1997; 
Reynolds, Puck, & Robinson, 1974; McCarthy Veach et al., 1999), these results may not 
mean a problem in the sensitivity of the items, but rather to reflect the counselees’ high 
level of satisfaction with the GC quality. Percentages of participants who answered using 
the upper (5) and intermediate (4) points of the Likert scale further support this hypothesis 
(see Appendix G for detailed results). Many potential causes may be advanced to explain 
this high degree of satisfaction with the GC. The CGS, which agreed to participate in the 
study, may offer in fact a high-quality service. Then the GC consultations are different 
from the typical medical consultations in terms of content, organization and duration. For 
example, the informational but also the emotional needs of the counselees are addressed. 
The professional usually give time for counselees to express their doubts and feelings 
about the disease and test. Moreover, in the case of a pre-symptomatic test (PST), the 
counselees receive besides the pre and post GC, a consultation with a psychologist before 
taking the decision about the genetic test. Other factors more related to the individual 
experience of the counselees, such as the meeting of their expectations of GC (e.g., Davey 
et al., 2005; Michie, Marteau, & Bobrow, 1997), the quality of the relationship established 
with the professional (e.g., MacLeod et al., 2002; Skirton, 2001) and the quality of the 
communication with the professional during the consultation (e.g., Meiser, Irle, Lobb, & 
Barlow-Stewart, 2008) could additionally contribute to their degree of satisfaction. These 
potential causes may aid to explain the high degree of satisfaction with GC quality found, 
but additional research is needed. In future studies, the analyses of the sensitivity of the 
items should be replicated with other samples. Indeed, despite the medium size of this 
sample, the number of CGS involved in this study is relatively small (N = 4). 
Comparing these findings with those found on the scale for professionals assessment 
of GC quality, a future comparison between the data collected from both scales seems to be 
possible. However, it is worth noticing that some differences were found. Concerning the 
‘genetic education’, compared with professionals, counselees more clearly separate the 
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provision of information from its understanding. Regarding the ‘counselee’s individual 
attributes’, counselees do not split so clearly the emotional experience of the motivations 
approach and decision-making support. Moreover, for the counselees the items “A consulta 
foi organizada de forma a responder às minhas necessidades”, “O profissional perguntou-
me e compreendeu o(s) motivo(s) do meu pedido de consulta” and “Tive a oportunidade de 
dar o meu consentimento informado” are more strongly associated with each other than 
with the remaining items. In respect of the potential effects, counselees more clearly 
separate the empowerment from the satisfaction, associating interestingly the items “Na 
consulta fiquei a saber mais sobre a doença e os aspetos relacionados” and “Ao longo da 
consulta as minhas dúvidas diminuíram” with the set of items related to the satisfaction. 
With regard to the services provision, for the counselees, the items “O tempo de espera 
pela consulta foi razoável” and “O tempo de espera pela comunicação dos resultados foi o 
previsto” are more strongly associated with each other than with the remaining items. 
These differences in the organization of the items resulted in the emergence of new 
components specific from the counselees’ perspective, namely the ‘counselee-centred 
care’, ‘satisfaction’ or ‘time management’. Different hypothesis may be advanced to 
explain these discrepancies. Firstly, the counselees and the professionals are answering the 
scale items from different perspectives, the counselees are evaluating the care received 
while the professionals are assessing their own practice. Then the respondents’ personality 
characteristics and their assumptions about the GC and its quality, as well as their 
expectations of the GC may also contribute to these differences. Looking specifically to the 
counselees’ characteristics, their health literacy and educational level may have influenced 
their comprehension and consequent evaluation of the items. Moreover, other factors, such 
as the counselees’ personal opinion of the professional who conducted the consultation, or 
their personal general impression of the hospital in which consultation taken place may 
also contribute to explaining these differences (Donabedian, 2005). It is also worth 
recognizing that some specific characteristics of the scales may have influenced these 
results. Further research with the combined application of both scales should be conducted 
to understand better these differences.  
In sum, the results of this study present preliminary evidence that the scale has 
adequate psychometric proprieties, namely construct validity and internal consistency. 
These results demonstrate that the scale may be used to measure how counselees evaluate 
the quality of GC and support the suitability of the REM as a useful conceptual framework 
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to evaluate the GC quality, as well as the content validity and cultural adequacy of the 
quality indicators selected. Representing an important addition to the empirical support 
obtained previously for this model and these quality indicators by Paneque and colleagues 
(2018). 
 
5.1. Strengths and limitations  
This scale is the first Portuguese measure of the counselee’s assessment of GC 
quality. The scale items were developed and refined through rigorous procedures of 
literature review and cognitive interview with members of the target population, in order to 
ensure their content and face validity. The decisions made in testing the scale structure, 
reliability and validity were clearly explained and followed empirical, theoretical and 
clinical criteria. The scale can be easily and quickly administered, which is an advantage in 
a healthcare context where time constraints are well-known.  
Some limitations of the present study must be acknowledged and taken into account 
in results interpretation.  
First, it should be noted that despite the empirical validation design being a strength 
of this study, the sample may be considered of medium size. Moreover, the generalizability 
of the findings may be limited by the potential response bias and lack of representativeness 
of the final sample. The sample is not representative of the broader Portuguese counselee’s 
population because not all national CGS had the opportunity to participate in the study. It 
is also possible to hypothesize that those which accepted to participate may be more 
concerned with the quality issues in their practice. Another limitation is that the sample 
was over-represented by women and by counselees who had a GC consultation within the 
predictive/presymptomatic setting, with a lower number of counselees who had a GC 
consultation in other clinical settings. It is not known whether or not this reflects the profile 
of the majority of GC consultations in Portugal because for ethical reasons, we could not 
collect any data from counselees who declined to participate. Furthermore, as information 
concerning participants who chose not to participate in the study was not collected, the 
participants included in this sample may have a greater interest in their health and 
healthcare quality, higher health literacy and higher expectations to their GC consultation 
than the general counselees. The use of the words “quality evaluation”, and the subsequent 
40 
 
perception of being evaluating the professionals and services performance, may have also 
biased counselee’s answers.  
Secondly, responses were not collected through the online version of the scale. This 
is consistent with findings reported previously in studies that compared data obtained by 
using different modes of administration of surveys (Nulty, 2008; Basílio et al., 2017). 
Nevertheless, it might be interesting for future studies to reflect on the reasons for 
counselees preference to answering to the paper version of the scale rather than to the 
online version, and potential strategies to increase the response rate to the online version.  
Thirdly, the scarcity of other measures validated with Portuguese counselees 
restricted the choice of variables that could be used as a reference to construct and external 
validity examination. 
Fourthly, confirmatory factor analysis and additional discriminant and convergent 
validity evidence may be useful to explore the structure and psychometric properties of the 
scale in more depth (Field, 2013). The use of a larger sample and the inclusion of 
counselees who had a GC consultation in other clinical contexts such as preconceptional 
and pre-natal, which are underrepresented in this sample, may be useful to further confirm 
the scale validity.  
Finally, in spite of the evidence of validity and reliability globally obtained in this 
study, further exploration of some items, which presented lower communality values 
and/or component loadings, may be worthwhile. The use of qualitative methodologies 
might be pertinent to understand more fully why those items did not present such good 
statistical results. 
 
5.2. Implications for Research and Practice and Recommendations for Future Studies 
The current study offers relevant contributions to the field of GC quality. Results 
showed that this instrument seems useful both in research and practice contexts.  
This is the first known scale for quality assessment by counselees which used REM 
as theoretical background and which is not exclusively focused on specific GC processes 
or effects. So this scale should facilitate future research in GC quality, allowing a better 
understanding of how counselees perceive GC process, which process aspects may affect 
the potential effects of GC, which are the more valued quality indicators across clinical 
settings, as well as the identification of training needs for professionals, or potential 
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additions to education curriculum of GC professionals. The knowledge gained from this 
scale application may then be used to improve the quality assessment routines at national 
services, to develop strategies to increase services support to the counselees and clinical 
interventions to maximize counselee’s benefits. The clinical usefulness of the scale was 
already recognized by national CGS, which accepted promptly to participate in the data 
collection.  
Finally, in the near future, it would be essential to define both procedures to calculate 
the scale scores and cut-off values to identify a GC with high quality. Later, when the 
services begin to use the scale, it would be important to examine the scale performance, as 
well as to continue its validation process, particularly by testing it in other counselee 
samples, as well as across countries and languages. Furthermore, as findings of this study 
are generally congruent with those previously obtained in the professionals’ scale 
validation study (Costa, 2017; Paneque et al., 2018), in the future, this line of research may 
be continued by testing and studying the combined application of both scales 
(professionals and counselees) aiming to achieve a comprehensive evaluation system of 
GC quality. 
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V. Conclusions 
In conclusion, the results of psychometric validation of the first Portuguese tool for 
assessing GC quality in a sample of Portuguese counselees who had a GC consultation in 
different clinical settings provide evidence that this scale is a valid and reliable tool, 
encouraging its application in clinical and research contexts.  
The development and validation of this scale is another step in the integration of the 
counselees’ perspective into the discussion of GC quality, providing a tool to investigate 
the counselees’ understanding of GC. Moreover, the scale provides new quality indicators 
specifically designed for counselees, based on scientific evidence and current clinical 
practices that can be useful for other researchers interested in monitoring the GC quality or 
study factors that influence the GC quality perception and its evaluation.  
Finally, it is also important to mention that this scale meets a well-identified need of 
the national professionals and CGS, as well as the demand of the World Health 
Organization (WHO, 2008) for more-patient centred care and a continuous healthcare 
quality improvement.   
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Appendix A. Summary of the main tools used in genetic counselling assessment 
 
Tool Author(s) and 
Publication’s Year 
Source Description 
Clinical Genetics Services 
Audit tool for Genetic 
Services (AWMGS) 
Skirton, Parsons, & 
Ewings (2005) 
EBSCO Aim: To Audit the clinical genetics 
services.  
Dimensions: (1) enhanced understanding; 
(2) positive psychological change; (3) 
respect for autonomy; (4) adaptation; (5) 
disequilibrium; and (6) value of contact. 
Sample of validation: 97 clients of a 
clinical genetics service.  
Reliability estimates: Not reported. 
Instrument for internal 
assessment of the 
quality of genetic 
counselling within a 
genetic counselling 
EuroGentest, Unit3 
(2010) 
EBSCO Aim: Internal assessment of the quality of 
genetic counselling within a genetic 
counselling clinic. This a measure created to 
the GC professionals. 
Dimensions: (1) size of and collaboration in 
the unit; (2) staff education; (3) physical 
environment and access; (4) waiting times; 
(5) prerequisite of counselling; (6) language, 
culture and communication; (7) decision-
making process and consent; (8) counselee 
experience; (9) extended support; (10) post-
consultation measures; and (11) guidelines. 
Reliability estimates: Not reported.  
Genetic counselling 
Outcome Scale (GCOS-
24) 
McAllister, Wood, 
Dunn, Shiloh, & 
Todd (2011) 
EBSCO Aim: To evaluate clinical genetics services. 
Number of items: 24.  
Sample of validation: 527 individuals who 
are affected by a genetic condition, or they 
are at-risk, or they are parents of a son with 
a genetic condition, or they are parents at-
risk for having an affected child. 
Reliability estimates: .86. 
Decision-Making 
Multidimensional 
Measure of Informed 
Michie, Dormandy, 
& Marteau (2002) 
EBSCO Aim: To assess if women made an informed 
decision.  
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Choice (MMIC) Dimensions: (1) Knowledge about prenatal 
screening; (2) attitude towards screening; 
and (3) actual decision.  
Sample of validation: 225 women who 
received low-risk results following serum 
screening for Down syndrome.  
Reliability estimates: Ranges from .68 to 
.78. 
Familial Communication 
Openness to Discuss 
Hereditary Cancer in the 
Family (ODCF) Scale 
 
 
 
 
 
Mesters, Van Den 
Borne, Mccormick, 
Pruyn, De Boer, & 
Imbos (1997) 
EBSCO Aim: To evaluate the openness to discuss 
cancer within the family.  
Number of items: 8 items. 
Sample of validation: 498 individuals with 
either breast cancer or Hodgkin's disease 
and 133 individuals with cancer in the head 
and neck.  
Reliability estimates: Ranges from .78 to 
.92. 
Family Communication 
Questionnaire (FCQ) 
Hughes, Lerman, 
Schwartz, Peshkin, 
Wenzel, Narod, 
Corio, Tercyak, 
Hanna, Isaacs, & 
Main (2002) 
EBSCO Aim: To assess family communication 
about genetic testing. 
Dimensions: (1) communication of 
BRCA1/2 test results; (2) length of time 
between receipt of BRCA1/2 test result and 
communication with relatives; (3) 
motivations for communicating BRCA1/2 
test results and motivations for not 
communicating BRCA1/2 test results; and 
(4) topics discussed with family members. 
Sample of validation: 43 women who were 
the first family member to have genetic 
testing. 
Reliability estimates: Not reported.  
Informing Relatives 
Inventory (IRI) 
Geus,  Aalfs,  
Menko, Sijmons, 
Verdam, Haes, & 
Smets (2015) 
EBSCO Aim: To assess counselee’s knowledge, 
motivation, and self-efficacy regarding the 
disclosure of hereditary cancer risk 
information to at-risk relatives. 
Dimensions: This is a battery of 
instruments that evaluate the following 
constructs: (a) counselee’s knowledge, (b) 
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motivation, and (c) (c) self-efficacy 
regarding the disclosure of hereditary cancer 
risk information to at-risk relatives. 
Sample of validation: 212 counselee’s 
visiting the Clinical Genetics department 
with regarding hereditary breast and/or 
ovarian cancer or colon cancer.  
Reliability estimates: Ranges from .82 to 
.90. 
Knowledge 
Measure of Counselee’s 
Knowledge of Down 
Syndrome 
Braitman & Antley 
(1978) 
EBSCO Aim: To assess knowledge and 
understanding of Down syndrome before 
and after genetic counselling. 
Dimensions: (1) genetic knowledge; (2) 
recurrence risk; and (3) prenatal diagnosis.  
Sample of validation: 126 individuals - 
nurses, graduate students in Medical 
Genetics, special education teachers, and 
parents of children with Down syndrome.  
Reliability estimates: .84. 
Maternal Serum 
Screening Knowledge 
Questionnaire 
(MSSKQ) 
Goel, Glazier, 
Holzapfel, Pugh, & 
Summers (1996) 
EBSCO Aim: To assess knowledge about maternal 
serum screening (MSS).  
Dimensions: (1) Knowledge of test 
characteristics; (2) indications for screening 
and timing; (3) ancillary tests; and (4) and 
target conditions. 
Sample of validation: 1084 women 
attending a maternal registration clinic. 
Reliability estimates: .74. 
Knowledge of Prenatal 
Screening and 
Diagnostic Tests 
Marteau, Johnston, 
Plenicar, Shaw, & 
Slack (1998) 
EBSCO Aim: To assess women’s knowledge about 
genetic tests that may be offered to them 
during their pregnancies.  
Number of items: 15 items divided in two 
parts: (1) familiarity and (2) knowledge.  
Sample of validation: 229 pregnant 
women, 69 women who had recently given 
birth, and 41 women who had never been 
pregnant. 
Reliability estimates: Ranges from .72 to 
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.85. 
Genetic Knowledge 
Index 
Furr & Kelly (1999) EBSCO Aim: To measure basic genetic knowledge.  
Number of items: 5 items.  
Sample of validation: 330 individuals of 
the general population.  
Reliability estimates: .74.  
Breast Cancer and 
Hereditary Knowledge 
Scale (BCHK) 
Ondrusek, Warner, 
& Goel (1999) 
EBSCO Aim: To measure the general knowledge 
about breast cancer and hereditary breast 
cancer (HBC) among women at low to 
moderate risk of HBC.  
Number of items: 11 items. 
Sample of validation: 36 women breast 
clinic patients and 11 women of the general 
population. 
Reliability estimates: Not reported.  
Breast Cancer Genetic 
Counselling Knowledge 
Questionnaire (BGKQ) 
Erblich, Brown, 
Kim, 
Valdimarsdottir, 
Livingston, & 
Bovbjerg (2005) 
EBSCO Aim: To evaluate the knowledge of 
information typically included in genetic 
counselling for breast cancer. 
Number of items: 27 items. 
Sample of validation: 45 individuals of the 
general population and 28 women who had 
attending genetic counselling consultations.  
Reliability estimates: .92. 
Measuring Genetic 
Knowledge: A Brief 
Survey Instrument for 
Adolescents and Adults 
Fitzgerald-Butt, 
Bodine, Fry, Ash, 
Zaidi, Garg, 
Gerhardt, & 
McBride (2016) 
EBSCO Aim: To assess the Basic knowledge of 
genetics. 
Number of items: 18 items divided into 2 
factors: (1) applied and (2) basic.  
Sample of validation: 465 parents of 
children with congenital heart defects and 
196 adolescents and young adults with 
congenital heart defects. 
Reliability estimates: Ranges from .66 to 
.73. 
Needs and Expectations 
QUOTE-gene
ca
 Pieterse, Van 
Dulmen, Ausems, 
Schoemaker, 
Beemer, & Bensing 
(2005) 
EBSCO Aim: To evaluate both counselee’s needs 
and preferences in genetic counselling for a 
hereditary cancer.  
Dimensions: (1) determination and meaning 
of being a carrier of a cancer gene; (2) 
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emotional aspects for counselee and family; 
(3) own risk of developing cancer; and (4) 
hereditary cancer in general.  
Sample of validation: 200 counselees 
referred for hereditary cancer, aged 18 years 
or older and being the first in the family 
seeking genetic counselling.  
Reliability estimates: Not reported.  
Parents’ Attitudes  
Pediatric BRCA1/2 
Testing 
Attitudes Scale (P-TAS) 
Peshkin, DeMarco, 
Garber, 
Valdimarsdottir, 
Patenaude, 
Schneider, 
Schwartz, & 
Tercyak (2009) 
EBSCO Aim: assess To measure parents’ attitudes 
and interests in pediatric BRCA1/2 testing. 
Dimensions: (1) attitudes and beliefs, and 
(2) decision-making and communication. 
Sample of validation: 187 mothers after 
pretest genetic counselling and provision of 
a blood sample for BRCA1/2 testing and 96 
mothers non-tested.  
Reliability estimates: Ranges from .70 to 
.80. 
Perceived Personal Control  
Perceived Personal 
Control (PCP) 
Berkenstadt, Shiloh, 
Barkay, Katznelson, 
& Goldman (1999) 
EBSCO Aim: To measure counselee’s subjective 
perceptions of how much control they 
consider they have over their genetic 
problem.  
Dimensions: (1) cognitive control; (2) 
decisional Control; and (3) behavioural 
control 
Sample of validation: 256 individuals that 
are attending a clinical genetics service due 
a genetic condition.  
Reliability estimates: Ranges from .83 to 
.86. 
Psychological Adjustment 
Multidimensional 
Impact of Cancer Risk 
Assessment 
Questionnaire (MICRA) 
Cella, Hughes, 
Peterman, Chang, 
Peshkin, Schwartz, 
Wenzel, Lemke, 
Marcus, & Lerman 
(2002) 
EBSCO Aim: To evaluate the impact of result 
communication after a genetic testing. 
Dimensions: (1) distress; (2) uncertainty; 
and (3) positive experiences. 
Sample of validation: 158 women, at-risk 
for a BRCA1 or BRCA2 mutation, who are 
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attending genetic counselling consultations.   
Reliability estimates: Ranges from .75 to 
.86. 
Psychological 
adaptation to Genetics 
information Scale 
(PAGIS) 
Read, Perry, & 
Duffy (2005) 
EBSCO Aim: To measure the psychological 
adaption to genetics information.  
Dimensions: (1) nonintrusiveness, (2) 
support, (3) self-worth, (4) certainty, and (5) 
self-efficacy. 
Sample of validation: 323 individuals with 
a genetic disease or members of a family 
with a genetic disease.  
Reliability estimates: .90. 
Psychosocial Aspects of 
Hereditary Cancer 
(PAHC) 
Questionnaire 
Eijzenga, Bleiker, 
Hahn, Kluijt, 
Sidharta, Gundy, & 
Aaronson (2014) 
EBSCO Aim: To evaluate specific psychosocial 
problems related to cancer genetic 
counselling 
Dimensions: (1) genetics, (2) practical 
issues, (3) family, (4) living with cancer, (5) 
emotions, and (6) children. 
Sample of validation: 127 counselees who 
are attending genetic counselling 
consultations. 
Reliability estimates: Not reported. 
Quality 
Portuguese Tool for 
Quality Assessment of 
Genetic counselling: a 
New Tool for 
Healthcare 
Professionals 
Paneque, Costa, 
Lemos, Alves-
Ferreira, Sequeiros, 
& Lemos (2018) 
EBSCO Aim: Health Professionals working in 
genetic counselling field (auto) evaluate the 
quality of their practice. 
Dimensions: (1) education; (2) counselee’s 
characteristics; (3) counsellor-counselee 
relationship; (4) effects of the process in the 
counselee; and (5) services provision. 
Sample of validation: 30 professionals 
working in genetic counselling field who 
evaluated 81 consultations.  
Reliability estimates: ranges from .83 to 
.92.   
Satisfaction  
Satisfaction with 
Genetic 
Counselling Scale 
Shiloh, Avdor, & 
Goodman (1990) 
EBSCO Aim: To measure the satisfaction with the 
genetic counselling.  
Dimensions: (1) instrumental, (2) affective 
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(SGCS) and (3) procedural. 
Sample of validation: 76 counselees of a 
genetic counselling center.  
Reliability estimates: Not reported.  
Genetic Counselling 
Satisfaction Scale 
(GCSS) 
De Marco, Peshkin, 
Mars, & Tercyak 
(2004) 
EBSCO Aim: To evaluate whether the board goals 
of genetic counselling were addressed. 
Number of items: 6. 
Sample of validation: patients seeking 
prenatal genetic counselling. 
Reliability estimates: .90. 
Self-Efficacy   
Genetic Counselling 
Self‐Efficacy Scale 
(GCSES) 
Caldwell, Wusik, 
He, Yager, & 
Atzinger (2018) 
EBSCO Aim: For (auto) evaluate their professional 
self-efficacy.  
Dimensions: (1) complex skills; (2) 
communication; (3) genetic testing; (4) 
basic psychosocial skills; (5) genetic 
counselling process; and (6) information 
gathering. 
Sample of validation: 20 genetic 
counselling students and 18 genetic 
counsellors. 
Reliability estimates: .96. 
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Appendix B. Reciprocal-engagement model of genetic counselling practice  
 
Tenets Goals Strategies Behaviours 
 
Genetics information is 
Key 
Patient is informed 
Counsellor knows what 
information to impart 
Counsellor presents 
genetics information 
Patient gains new 
perspectives 
 
Assess patient educational 
level 
Assess patient decision-
making style 
Assess medical literacy  
Listen for inaccuracy 
Two-way communication  
Use visual aids 
Assess patient 
understanding 
Open and closed 
questions to gather 
hx and to determine 
what patient 
understands 
Open and closed 
questions 
Ask questions 
Open and closed 
questions to 
determine patient 
understanding; 
repeat or rephrase 
information 
Explain materials; 
use language patient 
can understand 
Open and closed 
questions to learn 
what the 
information means 
to the patient 
Relationship is integral 
to genetic counselling 
Counsellor and patient 
establish a bond 
Good counsellor–patient 
communication 
Counsellor characteristics 
positively influence 
process 
Active listening 
Behave ethically 
Recognize impact on 
session  
Maintain objectivity 
Maintain boundaries Self-
care 
Peer supervision 
Sit quietly; reflect 
patient thoughts and 
feelings; summarize 
patient statements; 
rephrase; use similar 
body language 
Self-disclose; 
request feedback; 
provide feedback 
Patient autonomy must 
be supported 
Establish working contract 
Integrate familial and 
cultural context into 
counselling relationship 
and decisions 
Patient feels empowered 
and more in control 
Facilitate collaborative 
decisions 
Assess patient 
expectations  
Provide informed consent 
Establish realistic agenda 
Recognize multiple 
strategies Maintain 
counselling flexibility 
Discuss what patient 
wants to discuss Create 
safe environment  
Ask questions 
Describe process  
State goals 
Reflect patient 
thoughts and 
feelings re: options 
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Respect patient 
decision/viewpoint Enable 
informed actions and 
decisions 
Ask about options 
Patients are resilient Recognize patient 
strengths 
Adaptation 
Empowerment 
Identify patient strengths 
Make connections 
Anticipatory guidance 
Instill hope 
Assimilation 
Accommodation 
Create safe environment 
Maintain/enhance patient 
self-esteem Identify 
possible outcomes 
Ask questions about 
patient coping skills 
Patient emotions make a 
difference 
Counsellor and patient 
know pt concerns 
Patient family dynamics 
are understood by 
counsellor and patient. 
Patient self-esteem is 
maintained or increased 
Recognize ethical 
dilemmas in patient’s life  
Anticipate patient needs 
Define patient support 
network  
Identify resources Convey 
empathy 
 
Note. Adapted from “Coming Full Circle: A Reciprocal-Engagement Model of Genetic Counselling 
Practice” by P. McCarthy Veach, D. M. Bartels, and B. S. LeRoy, 2007, Journal of Genetic Counselling, 
16, p. 720 and p. 721. 
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Appendix C. Cognitive interview probes 
 
Protocol Probes 
a. Did you have doubts or hesitate in any question? 
(Conditional Probe) Please, tell me why you had doubts or hesitated in this (these) 
question(s)? 
b. What did you think when you read this (these) question(s)?  
c. In your words, what do you think that we intend to know with this question? 
d. Did you think that was easy or difficult to answer this question? 
e. Why did you choose this answer option? 
f. What do you think about the scale extension? 
g. What do you think about the instructions? 
Examples of Emergent Probes 
a. Is question 3.9. pertinent in your perspective? 
b. What is that word (or this sentence) means to you? 
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Appendix D. Scale items: Changes, reasons for change and final wording 
Original Wording Participant(s)  Reason(s) for Change Final Wording 
2.3. O profissional 
questionou-me acerca 
dos meus valores e 
crenças como por 
exemplo: religião, 
mitos, projetos de vida 
relacionados com o 
aconselhamento 
genético. 
Researcher who had 
participated in the 
professionals’ scale 
development 
Needed clarification. It 
is difficult to 
understand the item. 
Wording change – 
“perguntou-me” - was 
performed to improve 
the item face validity 
and its resemblance 
with the previous item.   
O profissional 
perguntou-me os meus 
valores e crenças 
relacionados com o 
aconselhamento 
genético, como por 
exemplo: religião, 
mitos, projetos de vida. 
2.5. Conversamos sobre 
a forma como os meus 
antecedentes pessoais e 
familiares, as minhas 
redes de apoio social, e 
a minha forma de lidar 
com as situações 
difíceis, se poderão 
relacionar com as 
minhas reações 
emocionais face ao meu 
diagnóstico. 
Researcher 
P4 
P6 
Needed clarification. 
The item is ambiguous. 
Word change – “neste 
contexto” - facilitates 
the comprehension of 
the item.  
Conversamos sobre a 
forma como os meus 
antecedentes pessoais e 
familiares, as minhas 
redes de apoio social, e 
a minha forma de lidar 
com as situações 
difíceis, se poderão 
relacionar com as 
minhas reações 
emocionais neste 
contexto. 
3.3. A consulta 
adaptou-se bem às 
minhas características 
(por exemplo: valores, 
preferências, forças e 
fraquezas). 
Researcher Needed clarification. 
Wording change - “o 
professional” - was 
performed to improve 
the item face validity 
and its resemblance 
with both previous and 
subsequent items.   
O profissional adaptou-
se bem às minhas 
características, como 
por exemplo: valores, 
preferências, forças e 
fraquezas. 
3.9. O profissional 
mostrou ser um 
especialista credível 
nesta área o que 
aumentou a minha 
Researcher 
P5 
Needed clarification. It 
is difficult to 
understand the item. 
Wording change - 
“mostrou estar bem 
O profissional mostrou 
estar bem preparado o 
que aumentou a minha 
confiança nele. 
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confiança nele. preparado” - was 
performed to improve 
the item face validity.  
4.4. A consulta 
contribuiu para eu lidar 
melhor com a doença e 
com o meu risco. 
P6 Needed clarification. 
The item is incomplete. 
Wording added – 
“e/ou” – as P6 
emphasized some 
counselees do not have 
a disease but they are at 
risk for a disease.  
A consulta contribuiu 
para eu lidar melhor 
com a doença e/ou com 
o meu risco. 
4.6. A consulta abriu-
me novas perspetivas. 
Researcher Needed clarification. It 
is difficult to 
understand the item. 
Wording change – “A 
deu-me novas formas 
de ver a minha 
situação” – to ease the 
item understanding.  
A consulta deu-me 
novas formas de ver a 
minha situação. 
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Appendix E. Reliability analysis of scale dimensions 
 
 
Item 
 
N 
Corrected item-
total correlations 
Cronbach’s alpha if 
item deleted 
Counselee’s Education  α =.70    
1.2. 105 .59 .62 
1.3. 105 .57 .63 
1.4. 105 .38 .72 
1.5. 105 .45 .66 
1.12. 105 .57 .62 
Counselee’s Understanding and Knowledge  α =.60   
1.1 105 .18 .61 
1.6. 105 .52 .50 
1.7. 105 .41 .56 
1.8. 105 .31 .58 
1.9. 105 .48 .54 
1.10. 105 .22 .65 
1.11. 105 .47 .50 
Counselee’s Individual Attributes α =.88    
2.1. 105 .64 .87 
2.2. 105 .59 .87 
2.4. 105 .55 .87 
2.5. 105 .61 .87 
2.6. 105 .71 .86 
2.7. 105 .75 .86 
2.8. 105 .73 .86 
2.9. 105 .70 .87 
2.10. 105 .44 .88 
2.11. 105 .50 .88 
Relationship and Communication Issues  α =.83    
3.1. 105 .59 .80 
3.2. 105 .63 .80 
3.3. 105 .44 .82 
3.4. 105 .68 .79 
3.5. 105 .67 .79 
3.6. 105 .54 .81 
3.7. 105 .64 .80 
3.9 105 .43 .82 
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Potential Effects α =.90    
4.1. 103 .78 .88 
4.2. 103 .64 .89 
4.3. 103 .55 .90 
4.4. 103 .70 .89 
4.5. 103 .70 .89 
4.6. 103 .65 .89 
4.7. 103 .68 .89 
4.8. 103 .75 .88 
4.9. 103 .72 .89 
4.10. 103 .52 .90 
Services Provision α =.73    
5.1. 102 .43 .71 
5.2. 102 .46 .70 
5.3. 102 .49 .70 
5.4. 102 .47 .70 
5.6. 102 .52 .71 
5.7. 102 .23 .75 
5.8. 102 .49 .70 
5.9. 102 .48 .70 
5.10. 102 .44 .70 
Note. Values were calculated using listwise option.  
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Appendix F. Descriptive statistics for the fifty-two items of the validation version of the 
scale 
 
Item M SD Sk Ku % of 
Missing 
Values 
1.1. Counselee’s expectations. 4.28 1.23 -2.08 4.17 .9% 
1.2. Information about the disease. 4.52 .98 -2.45 6.36 .9% 
1.3. Information about the genetic test. 4.57 .86 -2.66 8.98 .9% 
1.4. Information about reproductive alternatives. 3.52 1.99 -.99 -.71 1.9% 
1.5. Information about support sources and resources 
(e.g., patients associations). 
3.16 1.80 -.55 -1.1  
1.6. Questions about counselee’s understanding. 4.31 1.14 -1.97 3.86  
1.7. Language clarity. 4.64 .76 -3 12.80  
1.8. Doubts. 4.66 .76 -3.09 12.89  
1.9. Information usefulness. 4.52 .90 -2.41 7.03  
1.10. Audiovisual and didactic materials. 2.24 1.98 .24 -1.55 .9% 
1.11. Resume information provided. 3.20 1.62 -.50 -.88  
1.12. Confidentially. 4.48 1.13 -2.60 6.71  
2.1. Consultation meeting my needs. 4.55 .85 -2.27 6.81 .9% 
2.2. Counselee’s reason for consultation. 4.52 1.1 -2.91 8.91 .9% 
2.3.Values and beliefs related with genetic 
counselling (e.g., religion). 
2.62 1.97 -.06 -1.61 .9% 
2.4. How counselees and their families cope with the 
disease. 
4.07 1.41 -1.51 1.38 .9% 
2.5. Counselee’s emotional reactions.   4.01 1.45 -1.51 1.28 .9% 
2.6. Expression of emotions during the consultation. 4.44 1.01 -2.09 4.58  
2.7. Life changes caused by genetic test. 4.28 1.24 -1.87 3.05  
2.8. Genetic test pros and cons. 4.16 1.35 -1.76 2.50  
2.9. Feeling secure during the consultation. 4.58 .83 -2.47 8.24  
2.10. Informed consent. 4.38 1.29 -2.44 5.40  
2.11. Next steps after the consultation. 4.59 1.06 -3.34 11.56  
3.1. Counselee’s acceptance. 4.61 .87 -2.78 9.28  
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3.2. Active listening 1. 4.73 .71 -3.78 19.06  
3.3. Counselee-centered consultation. 4.40 1.12 -2.56 7.15  
3.4. Nondirectiveness 1. 3.79 1.68 -1.08 -.31 .9% 
3.5. Nondirectiveness 2. 3.83 1.63 -1.22 .07  
3.6. Nondirectiveness 3. 4.22 1.34 -1.83 2.43  
3.7. Counselee-professional communication. 4.67 .81 -3.33 13.39 .9% 
3.8. Active listening 2. 4.45 1.12 -2.78 8.08  
3.9. Professional’s expertise. 4.72 .82 -4.11 19.66  
4.1. Disease knowledge improvement. 4.44 .97 -1.99 4.39  
4.2. Doubts decrease. 4.33 1.11 -1.88 3.58 .9% 
4.3. Empowerment 1. 4.05 1.44 -1.71 2.26  
4.4. Coping with disease and/or risk. 4.04 1.40 -1.64 2.02  
4.5. Empowerment 2. 4.13 1.29 -1.65 2.18  
4.6. New perspectives. 3.84 1.52 -1.30 .76 .9% 
4.7. Counselee-professional relationship.   4.34 1.09 -2.09 5.13  
4.8. Expectations meeting. 4.52 .95 -2.31 5.88 .9% 
4.9. Satisfaction 1. 4.63 .82 -2.81 9.89 .9% 
4.10. Satisfaction 2. 4.60 1 -3.17 11.06  
5.1. Consultation duration. 4.49 .86 -2.03 5.76  
5.2. Consultation preparation 1. 3.09 2.02 -.52 -1.38 .9% 
5.3. Consultation preparation 2. 3.10 2.08 -.59 -1.35 1.9% 
5.4. Time management 1. 4.07 1.22 -1.42 1.72  
5.5. Audiovisual and didactic materials. 1.96 2.05 .34 -1.61 .9% 
5.6. Privacity. 4.72 .72 -3.62 17.27  
5.7. Time management 2. 3.47 2 -.95 -.77 .9% 
5.8. Clinical team muldisciplinarity. 4.47 1.11 -2.75 8.09 .9% 
5.9. Openness for other family members. 4.25 1.49 -2.22 3.75 .9% 
5.10. Openness for future contacts. 4.48 1.23 -2.84 7.56  
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Appendix G. Responses distribution for the fifty-two items of the validation version of the 
scale 
 
 Frequencies (%) 
Item 1 2 3 4 5 NA 
1.1. Counselee’s expectations. 1.9% .9% 13.2% 16% 64.2% 3.8% 
1.2. Information about the disease. 1.9% 1.9% 8.5% 13.2% 73.6% .9% 
1.3. Information about the genetic test. .9%  9.4% 16% 72.6% .9% 
1.4. Information about reproductive 
alternatives. 
2.9% 1% 10.5% 12.4% 53.3% 20% 
1.5. Information about support sources 
and resources (e.g., patients associations). 
10.3% 10.3% 14% 18.7% 33.6% 13.1% 
1.6. Questions about counselee’s 
understanding. 
2.8% 1.9% 12.1% 18.7% 62.6% 1.9% 
1.7. Language clarity.   7.5% 16.8% 74.8% .9% 
1.8. Doubts.   8.4% 12.1% 78.5% .9% 
1.9. Information usefulness. .9% .9% 10.3% 15.9% 71% .9% 
1.10. Audiovisual and didactic materials. 18.9% 6.6% 12.3% 10.4% 22.6% 29.2% 
1.11. Resume information provided. 13.1% 7.5% 27.1% 14% 30.8% 7.5% 
1.12. Confidentially. 1.9% .9% 8.4% 11.2% 74.8% 2.8% 
2.1. Consultation meeting my needs.   14.2% 12.3% 72.6% .9% 
2.2. Counselee’s reason for consultation.   9.4% 10.4% 76.4% 3.8% 
2.3. Values and beliefs related with 
genetic counselling (e.g., religion). 
20.8% 2.8% 16% 10.4% 29.2% 20.8% 
2.4. How counselees and their families 
cope with the disease. 
5.7% 2.8% 15.1% 13.2% 59.4% 3.8% 
2.5. Counselee’s emotional reactions.   5.7% 3.8% 11.3% 18.9% 55.7% 4.7% 
2.6. Expression of emotions during the 
consultation. 
1.9% 1.9% 12.1% 14% 69.2% .9% 
2.7. Life changes caused by genetic test. 1.9% 4.7% 12.1% 12.1% 66.4% 2.8% 
2.8. Genetic test pros and cons. 1.9% 3.7% 14% 14% 61.7% 4.7% 
2.9.Feeling secure during the 
consultation. 
  12.1% 13.1% 73.8% .9% 
2.10. Informed consent.  1.9% 8.4% 11.2% 72.9% 5.6% 
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2.11. Next steps after the consultation.   5.6% 11.2% 79.4% 3.7% 
3.1. Counselee’s acceptance. .9%  10.3% 10.3% 77.6% .9% 
3.2. Active listening 1.   5.6% 11.2% 82.2% .9% 
3.3. Counselee-centered consultation.  .9% 9.3% 19.6% 66.4% 3.7% 
3.4. Nondirectiveness 1. 12.3% 3.8% 11.3% 9.4% 57.5% 5.7% 
3.5. Nondirectiveness 2. 12.1% .9% 10.3% 16.8% 54.2% 5.6% 
3.6. Nondirectiveness 3. 6.5% .9% 10.3% 14% 65.4% 2.8% 
3.7.Counselee-professional 
communication. 
.9%  6.6% 11.3% 80.2% .9% 
3.8. Active listening 2. .9%  6.5% 19.6% 69.2% 3.7% 
3.9. Professional’s expertise.   4.7% 9.3% 84.1% 1.9% 
4.1. Disease knowledge improvement. .9% 1.9% 14% 14% 68.2% .9% 
4.2. Doubts decrease. .9% 3.8% 14.2% 14.2% 65.1% 1.9% 
4.3. Empowerment 1. .9% .9% 17.8% 15.9% 57% 7.5% 
4.4. Coping with disease and/or risk. 2.8% 2.8% 14% 20.6% 54.2% 5.6% 
4.5. Empowerment 2. 4.7% 1.9% 15% 18.7% 57% 2.8% 
4.6. New perspectives. 5.7% .9% 20.8% 16% 50% 6.6% 
4.7. Counselee-professional relationship.    .9% 16.8% 15.9% 63.6% 2.8% 
4.8. Expectations meeting. .9% 1.9% 11.3% 11.3% 73.6% .9% 
4.9. Satisfaction 1.  .9% 9.4% 10.4% 78.3% .9% 
4.10. Satisfaction 2.   9.3% 7.5% 80.4% 2.8% 
5.1. Consultation duration.   15% 16.8% 67.3% .9% 
5.2. Consultation preparation 1. 9.4% 2.8% 15.1% 10.4% 41.5% 20.8% 
5.3. Consultation preparation 2. 3.8% 1% 15.2% 12.4% 41.9% 25.7% 
5.4. Time management 1. 4.7% .9% 21.5% 19.6% 51.4% 1.9% 
5.5. Audiovisual and didactic materials. 7.5% 1.9% 14.2% 13.2% 17.9% 45.3% 
5.6. Privacity.   6.5% 10.3% 82.2% .9% 
5.7. Time management 2.  2.8% 12.3% 11.3% 51.9% 21.7% 
5.8. Clinical team muldisciplinarity.   10.4% 13.2% 72.6% 3.8% 
5.9. Openness for other family members.   5.7% 16% 68.9% 9.4% 
5.10. Openness for future contacts.   6.5% 11.2% 76.6% 5.6% 
Note. Presented  percentages are valid percentages.  
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